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Why GAO Did This Study 
Nanotechnology involves the ability to 
control matter at approximately 1 to 
100 nanometers. Worldwide trends 
suggest that products that rely on 
nanotechnology will be a $3 trillion 
market by 2020. However, some of the 
EHS impacts of nanotechnology are 
unknown. The NSTC coordinates and 
oversees the NNI, an interagency 
program that, among other things, 
develops national strategy documents 
for federal efforts in nanotechnology.  
In this context, GAO examined:  
(1) changes in federal funding for 
nanotechnology EHS research from 
fiscal years 2006 to 2010; (2) the 
nanomaterials that NNI member 
agencies’ EHS research focused on in 
fiscal year 2010; (3) the extent to which 
NNI member agencies collaborate with 
stakeholders on this research and 
related strategies; and (4) the extent to 
which NNI strategy documents address 
desirable characteristics of national 
strategies. GAO’s review included 
seven NNI agencies that funded 93 
percent of the EHS research dollars in 
fiscal year 2010. This report is based on 
analysis of NNI and agency documents 
and responses to a questionnaire of 
nonfederal stakeholders. 
What GAO Recommends 
GAO recommends that the Director of 
the Office of Science and Technology 
Policy (OSTP), which administers the 
NSTC, (1) coordinate development of 
performance information for NNI EHS 
research needs and publicly report this 
information; and (2) estimate the costs 
and resources necessary to meet the 
research needs. OSTP and the seven 
included agencies neither agreed nor 
disagreed with the recommendations. 
What GAO Found 
From fiscal years 2006 to 2010, the National Science and Technology Council 
(NSTC) reported more than a doubling of National Nanotechnology Initiative (NNI) 
member agencies’ funding for nanotechnology environmental, health, and safety 
(EHS) research––from approximately $38 million to $90 million. Reported EHS 
research funding also rose as a percentage of total nanotechnology funding over 
the same period, ending at about 5 percent in 2010. However, GAO identified 
several reporting problems that raise concerns about the quality of EHS funding 
data reported. For example, for 18 percent of the 2010 projects GAO reviewed 
that were reported as EHS research, it was not clear that the projects were 
primarily directed at EHS risks. In addition, NNI member agencies did not always 
report funding using comparable data. The absence of detailed guidance on how 
agencies should report funding for their nanotechnology research has contributed 
to these problems, as GAO also reported in 2008 and made a related 
recommendation. 
In 2010, EHS research at the NNI member agencies GAO reviewed most 
frequently focused on carbon nanotubes, nanosilver, and nanoscale titanium 
dioxide. NNI has not prioritized nanomaterials for EHS research, but NNI’s 2011 
EHS research strategy outlines criteria for NNI member agencies to use in doing 
so. It is too soon to tell how these criteria will influence NNI member agencies’ 
decisions about which nanomaterials to prioritize, and it is unclear if information 
needed to use the NNI criteria is available. 
The NNI member agencies have collaborated extensively on EHS research and 
strategies. They have collaborated through the NSTC to develop joint EHS 
research strategies and have initiated numerous formal collaborative EHS 
research projects. Nonfederal stakeholders who responded to GAO’s web-based 
questionnaire on nanotechnology EHS research told GAO that they benefited 
from collaboration with the NNI member agencies but identified some challenges, 
including a lack of funding and limited awareness of collaboration opportunities, 
among others. Most respondents rated the 2011 NNI EHS research strategy as 
somewhat or very effective at addressing nanotechnology EHS research needs. 
NNI strategy documents for EHS research issued by the NSTC address two and 
partially address the other four of the six desirable characteristics of national 
strategies identified by GAO that offer a management tool to help ensure 
accountability and more effective results. For example, the NNI strategy 
documents provide a clear statement of purpose, define key terms, and discuss 
the quality of currently available data, among others. However, they do not 
include performance information—such as performance measures, targets, and 
time frames for meeting those measures—that would allow stakeholders to 
evaluate progress towards the goals and research needs of the NNI. In addition, 
the documents do not include, or sufficiently describe, estimates of the costs and 
resources needed for the strategy. Without this information, it may be difficult for 
agencies and stakeholders to implement the strategy and report on progress 
toward achieving the research needs and assess if investments are 
commensurate with costs of the identified needs. View GAO-12-427. For more information, 
contact Frank Rusco at (202) 512-3841 or 
ruscof@gao.gov. 
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United States Government Accountability Office 
Washington, DC 20548 
May 21, 2012 
The Honorable Barbara Boxer 
Chairman 
Committee on Environment  
 and Public Works 
United States Senate 
Dear Madam Chairman: 
Nanotechnology is the understanding and control of matter at 
approximately 1 and 100 nanometers, known as the nanoscale. For 
illustration, a sheet of paper is about 100,000 nanometers thick, a human 
hair is about 80,000 nanometers in diameter, and three gold atoms lying 
side by side are about 1 nanometer long. Unusual properties can emerge 
in materials manufactured at the nanoscale—including electrical, 
magnetic, mechanical, optical, and thermal properties—that differ in 
important ways from the properties of conventionally scaled materials. 
Materials at this scale that have been manufactured are sometimes 
referred to as engineered nanomaterials.1 Nanotechnology has enabled 
or facilitated novel research in areas such as computing, medicine, 
energy conversion and storage, water purification, agriculture and food 
systems, synthetic biology, aerospace, and geoengineering. Consumer 
products that incorporate nanotechnology are as diverse as clothing, 
cosmetics, household appliances, and sporting goods. For example, 
nanoscale particles of titanium dioxide used in sunscreens act as physical 
filters that absorb UV light without affecting the opacity of the product. A 
2010 study estimated that values for products enabled by nanotechnology 
were worth about $91 billion in the United States and $254 billion 
worldwide in 2009.2
                                                                                                                       
1Nanomaterials may also occur naturally, such as components of volcanic ash or ocean 
spray, or be created incidentally, including as byproducts of welding. Our review focuses 
on engineered nanomaterials. When the term nanomaterial is used in our report, it refers 
to engineered nanomaterials. 
 Trends suggest that the number of nanotechnology 
products and workers employed in related fields will double every 3 years 
worldwide, achieving a $3 trillion market and 6 million workers by 2020. 
2Mihail C. Roco, Chad A. Mirkin, and Mark C. Hersam, eds., Nanotechnology Research 
Directions for Societal Needs in 2020 (Netherlands: Springer, 2010). 
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Even with its increasing commercialization, much remains unknown about 
nanotechnology, including some of the environmental, health, and safety 
(EHS) impacts of nanomaterials. For example, there are few tools and 
methods—such as models to predict the behavior of nanomaterials in the 
environment—for conducting research. It is difficult to assess the risk of 
nanomaterials because these materials are too varied to generalize how 
they will behave; nonetheless, risks associated with particular uses of 
specific nanomaterials can be assessed. Further, there is little information 
on the number of workers exposed to nanomaterials in the workplace or 
the effects on human health of such exposure. However, as we reported 
in 2010, some research indicates that the toxicity of certain 
nanomaterials, such as some forms of carbon nanotubes and nanoscale 
titanium dioxide, may pose a risk to human health.3
The National Nanotechnology Initiative (NNI) is a federal interagency 
program that seeks to expedite the discovery, development, and 
deployment of nanoscale science, engineering, and technology to serve 
the public good through coordinated research and development aligned 
with the missions of its member agencies.
 
4
                                                                                                                       
3GAO, Nanotechnology: Nanomaterials Are Widely Used in Commerce, but EPA Faces 
Challenges in Regulating Risk, 
 The NNI informs and 
influences the federal nanotechnology budget and planning process 
through its member agencies and through the National Science and 
Technology Council (NSTC), an entity administered by the Office of 
Science and Technology Policy (OSTP) that is the principal means by 
which the executive branch coordinates science and technology policy. 
The NSTC’s Committee on Technology coordinates the NNI under the 
Nanoscale Science, Engineering, and Technology (NSET) Subcommittee. 
The National Nanotechnology Coordination Office (NNCO), which reports 
to the Committee on Technology, provides technical and administrative 
GAO-10-549 (Washington, D.C.: May 25, 2010). 
4As of 2010, the NNI member agencies include the Departments of Defense, Education, 
Energy, Homeland Security, Justice, Labor, State, Treasury, and Transportation; the 
Department of Agriculture’s National Institute of Food and Agriculture and Forest Service; 
the Department of Commerce’s Bureau of Industry and Security, National Institute of 
Standards and Technology, and the U.S. Patent and Trademark Office; the Department of 
Health and Human Services’ Food and Drug Administration, National Institute for 
Occupational Safety and Health, and the National Institutes of Health; the Department of 
the Interior’s U.S. Geological Survey; the Consumer Product Safety Commission; 
Environmental Protection Agency; intelligence agencies; the International Trade 
Commission; National Aeronautics and Space Administration; Nuclear Regulatory 
Commission; National Science Foundation; Office of Management and Budget; and Office 
of Science and Technology Policy. 
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support to the NSET. The NNI, through the NNCO and appropriate 
agencies, among others, is directed to (1) establish goals, priorities, and 
metrics for evaluation for federal nanotechnology research, development, 
and other activities; (2) invest in federal research and development 
programs in nanotechnology and related sciences to achieve these goals; 
and (3) provide for interagency coordination of federal nanotechnology 
research, development, and other activities. 
The federal nanotechnology commitment is significant. Cumulative 
reported NNI funding since fiscal year 2001 amounts to more than $14 
billion. Nanotechnology research projects and activities undertaken by the 
NNI member agencies are categorized into eight program component 
areas.5
The NSTC issued three key NNI strategy documents in 2011 that, as a 
whole, seek to establish shared goals and research needs; describe NNI 
member agencies’ activities; and provide guidance for agency leaders, 
program managers, and the research community regarding planning and 
implementation of nanotechnology research and development 
investments and activities, including those related to EHS research.
 Agencies report their research funding for each program 
component area to the Office of Management and Budget (OMB) as part 
of the annual federal budget process. The seventh program component 
area comprises research “primarily directed at understanding the EHS 
impacts of nanotechnology development and corresponding risk 
assessment, risk management, and methods for risk mitigation,” which 
we refer to in this report as EHS research. 
6
                                                                                                                       
5The eight program component areas are (1) fundamental nanoscale phenomena and 
processes; (2) nanomaterials; (3) nanoscale devices and systems; (4) instrumentation 
research, metrology, and standards for nanotechnology; (5) nanomanufacturing; (6) major 
research facilities and instrumentation acquisition; (7) environment, health, and safety; 
and (8) education and societal dimensions. 
 
Jointly, these documents form a national strategy for federal 
nanotechnology efforts—such strategies tend to cut across sectors of the 
6These three strategy documents are: (1) NSTC, Committee on Technology, 
Subcommittee on Nanoscale Science, Engineering, and Technology, National 
Nanotechnology Initiative Strategic Plan (February 2011); (2) NSTC, Committee on 
Technology, Subcommittee on Nanoscale Science, Engineering, and Technology, 
National Nanotechnology Initiative Environmental, Health, and Safety Research Strategy 
(October 2011); and (3) NSTC, Committee on Technology, Subcommittee on Nanoscale 
Science, Engineering, and Technology, The National Nanotechnology Initiative 
Supplement to the President’s 2012 Budget (February 2011). 
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economy and levels of government and involve a range of public and 
private organizations and entities.7
In prior work, we have identified six desirable characteristics for national 
strategies and reviewed strategies that the federal government has used 
to plan for and report on crosscutting issues including emergency 
preparedness, financial literacy, influenza, and terrorism for these 
characteristics.
 The 2011 NNI strategic plan provides 
a vision and overarching goals for the program, including responsible 
development of nanotechnology, which includes EHS research. The 2011 
NNI EHS research strategy expands on the goal of the responsible 
development of nanotechnology by describing the state of science and 
research needed to ensure that nanotechnology provides maximum 
benefits to the environment and human well-being. The NNI Supplement 
to the President’s 2012 Budget serves as the annual report for the NNI 
and describes recent activities by the NNI member agencies and funding 
of the NNI, including the funding level for the program component area 
related to EHS research. These NNI strategy documents are the principal 
public record of the NSTC’s coordinating activities and reflect the NSTC’s 
guidance to agencies as they separately determine their budgets and 
activities for nanotechnology EHS research. 
8
                                                                                                                       
7These documents also describe mechanisms for outreach and collaboration with 
stakeholders who are involved in nanotechnology EHS research, including those working 
in state and local governments, academia, companies, and nongovernmental 
organizations. 
 These desirable characteristics help shape the policies, 
programs, priorities, resource allocations, and standards that would 
enable federal agencies and other stakeholders to implement the 
strategies and achieve the identified results. National strategies that 
address these characteristics offer policymakers and implementing 
agencies a management tool that can help ensure accountability and 
more effective results. 
8GAO, National Capital Region: 2010 Strategic Plan is Generally Consistent with 
Characteristics of Effective Strategies, GAO-12-276T (Washington, D.C.: Dec. 7, 2011); 
Influenza Pandemic: Further Efforts Are Needed to Ensure Clearer Federal Leadership 
Roles and an Effective National Strategy, GAO-07-781 (Washington, D.C.: Aug. 14, 
2007); Financial Literacy and Education Commission: Further Progress Needed to Ensure 
an Effective National Strategy, GAO-07-100 (Washington, D.C.: Dec. 4. 2006); Combating 
Terrorism: Evaluation of Selected Characteristics in National Strategies Related to 
Terrorism, GAO-04-408T (Washington, D.C.: Feb. 3, 2004). 
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In this context, you asked us to review federal nanotechnology EHS 
research. This report examines (1) changes in federal funding for 
nanotechnology EHS research from fiscal years 2006 to 2010; (2) the 
nanomaterials that NNI member agencies focused on in their EHS 
research in fiscal year 2010; (3) the extent to which NNI member 
agencies collaborate with stakeholders on nanotechnology EHS research 
and related strategies; and (4) the extent to which NNI strategy 
documents address desirable characteristics of national strategies. 
To conduct this work, we reviewed EHS research efforts funded by seven 
NNI agencies, which collectively funded 93 percent of EHS research 
dollars in fiscal year 2010: the National Science Foundation (NSF), 
National Institutes of Health (NIH), Environmental Protection Agency 
(EPA), National Institute for Occupational Safety and Health (NIOSH), 
Food and Drug Administration (FDA), National Institute of Standards and 
Technology (NIST), and the Consumer Product Safety Commission 
(CPSC). The first six of these agencies represent the top six providers of 
EHS research funding from fiscal year 2006 to fiscal year 2010, and 
CPSC has an important role in ensuring the safe use of nanotechnology 
in consumer products. 
To examine recent changes in federal funding for nanotechnology EHS 
research, we reviewed information published by NSTC in the NNI 
Supplements to the President’s Budget. Specifically, we reviewed funding 
reported in each program component area for fiscal years 2006 through 
2010 for all NNI member agencies funding nanotechnology research.9 For 
the dollar amounts that we adjusted for inflation, we used the Biomedical 
Research and Development Price Index to report funding in constant 
2010 dollars.10
                                                                                                                       
9See NSTC, Committee on Technology, Subcommittee on Nanoscale Science, 
Engineering, and Technology, The National Nanotechnology Initiative Supplement to the 
President’s 2012 Budget (February 2011); The National Nanotechnology Initiative 
Supplement to the President’s 2011 Budget (February 2010); The National 
Nanotechnology Initiative Supplement to the President’s 2010 Budget (May 2009); The 
National Nanotechnology Initiative Supplement to the President’s 2009 Budget 
(September 2008); and The National Nanotechnology Initiative Supplement to the 
President’s 2008 Budget (July 2007). 
 We consulted with agency and OMB officials to determine 
10The Biomedical Research and Development Price Index is prepared by the Department 
of Commerce, Bureau of Economic Analysis for use of and publication by NIH. Information 
about the index is available at 
http://officeofbudget.od.nih.gov/pdfs/FY13/BRDPI_Proj_Jan_2012_Final.pdf. 
 
  
 
 
 
Page 6 GAO-12-427  Nanotechnology 
the type of budget information reported in these documents for the 
agencies’ investments. For fiscal year 2010, the most recent year for 
which agencies’ nanotechnology investment data were available, we also 
collected quantitative and qualitative project-level data on all research 
projects that the seven selected agencies had categorized as EHS 
research (program component area 7). The agencies do not report 
project-level data to OMB annually but report their total EHS research 
funding to OMB annually for inclusion in the NNI budget supplements 
published by NSTC. Therefore, we reviewed data on the individual 
projects included in the agencies’ total EHS research funding in 2010. To 
assess the reliability of the agencies’ data, we obtained information 
regarding the data and the information systems used to produce and 
store them. We also reviewed related supporting documentation and 
consulted with agency officials. From our assessment, we determined 
that the data were sufficiently reliable for our purposes. We analyzed 
these data and consulted with agency officials to assess whether the 
agencies had appropriately categorized as EHS research the projects 
they reported as program component area 7—research “primarily directed 
at understanding the EHS impacts of nanotechnology development and 
corresponding risk assessment, risk management, and methods for risk 
mitigation.” We also reviewed our 2008 report in this area,11 which found 
that 22 of 119 fiscal year 2006 projects reported as EHS research were 
miscategorized, and recommended that the Director of OSTP, in 
consultation with the Directors of NNCO and OMB, provide better 
guidance to agencies on how to report nanotechnology EHS research. To 
identify the nanomaterials studied by the fiscal year 2010 EHS research 
projects, we reviewed qualitative project data such as abstracts for the 
projects we determined were primarily directed at EHS and consulted with 
agency officials. We then grouped the nanomaterials into five 
categories.12
To determine the extent to which the NNI agencies collaborate with 
stakeholders on nanotechnology EHS research and related strategies, we 
(1) discussed with agency officials how their agencies collaborate on 
 
                                                                                                                       
11GAO, Nanotechnology: Better Guidance Is Needed to Ensure Accurate Reporting of 
Federal Research Focused on Environmental, Health, and Safety Risks, GAO-08-402 
(Washington, D.C.: Mar. 31, 2008). 
12The five categories are carbon-based nanomaterials, metal-based nanomaterials, 
semiconductor-based nanomaterials, organic nanomaterials, and other nanomaterials. 
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nanotechnology EHS research and NNI’s role in facilitating that 
collaboration and (2) obtained documentation on these collaborative 
efforts. We conducted a review of formal collaborative efforts that focused 
on nanotechnology EHS research initiated from February 2008 to October 
2011. We administered a web-based questionnaire to a nonprobability 
sample of 223 nonfederal stakeholders, including those affiliated with 
academia, companies, nongovernmental organizations (NGO), and state 
and local governments, to obtain their views on collaboration with the NNI 
member agencies on EHS research and the NNI EHS research 
strategies. Of the 223, 138 completed the questionnaire, for an overall 
response rate of 62 percent. This sample included individuals who had 
expertise in the field of nanotechnology, had interacted with the NNI in the 
past few years, or who were representatives of organizations and 
companies suggested to us through our scoping interviews. 
To determine the extent to which the NNI strategy documents address 
desirable characteristics of national strategies, we analyzed three key 
NNI strategy documents related to nanotechnology EHS for the presence 
of six desirable characteristics we previously identified for national 
strategies. We also reviewed NNI member agencies’ management 
documents for the use of performance information related to 
nanotechnology EHS research and the extent to which they were linked 
with the NNI national priorities. Appendix I presents a more detailed 
description of our scope and methodology. 
We conducted this performance audit from February 2011 through May 
2012 in accordance with generally accepted government auditing 
standards. Those standards require that we plan and perform the audit to 
obtain sufficient, appropriate evidence to provide a reasonable basis for 
our findings and conclusions based on our audit objectives. We believe 
that the evidence obtained provides a reasonable basis for our findings 
and conclusions based on our audit objectives. 
 
Nanomaterials come in a variety of forms based both on their chemical 
composition and physical structure. For example, carbon-based 
nanomaterials can be produced in a number of physical structures such 
as sheets (graphene), tubes (carbon nanotubes), and particles (carbon 
black). Nanomaterials can enter the marketplace as materials 
themselves, as intermediates that either have nanoscale features or 
incorporate nanomaterials, and as final nano-enabled products. 
Background 
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The use of nanomaterials in commercial applications raises questions 
about the potential risks that might arise from exposures to nanomaterials 
and the differences in exposure during their manufacture, use, and 
disposal. For example, some, but not all, research studies have shown 
adverse respiratory or cellular effects in animals exposed to some types 
of carbon nanotubes. Observed effects include early onset and 
persistence of pulmonary fibrosis and interference with cell division.13
Efforts to examine EHS risks are complicated by the variety of 
nanomaterials available for research and commerce. According to the 
National Research Council (NRC) of the National Academies, a nonprofit 
institution providing scientific advice, there are currently gaps in 
understanding what factors or underlying phenomena contribute to 
potential hazards from nanomaterials.
 The 
risk posed by a material is a combination of the hazard or negative effect 
that material may have on an organism and the extent of the organism’s 
exposure to that material. Therefore, a highly poisonous material—that is, 
one with high hazard—may nonetheless pose little risk if susceptible 
groups have little or no contact with the material. For instance, many 
household chemicals are hazardous to human health but pose little risk 
when exposure is limited by safe handling. Conversely, a material with 
relatively mild health effects may pose a large risk if people or the 
environment are exposed to large amounts or over prolonged periods. 
14 In 2010, we reported that size 
alone is not a sufficient indicator of the potential risk of a material.15
                                                                                                                       
13In this report, we did not attempt to summarize the current scientific literature on the 
potential hazards of or exposure to nanomaterials. We most recently reviewed what is 
known about the potential human health and environmental risks of nanomaterials in 
2010, see 
 
Research on carbon nanotubes, for example, suggests that length, purity, 
and other factors may be involved as well. Similarly, data on potential 
exposures of people and the environment are incomplete. In the absence 
of clear indicators of risk, some organizations sponsoring research on 
nanomaterials have identified specific materials or classes of materials as 
high-priority targets for EHS testing based on availability and commercial 
interest. For example, as part of a testing program of the EHS risks of 
nanomaterials, the Organisation for Economic Co-operation and 
GAO-10-549. 
14NRC, A Research Strategy for Environmental, Health, and Safety Aspects of 
Engineered Nanomaterials (2012). 
15GAO-10-549. 
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Development has developed a list of 13 representative manufactured 
nanomaterials now or soon to be in commerce as priority testing 
targets.16,17
Regulatory agencies, like FDA, CPSC, and EPA, may not have complete 
information on the uses or risks of some nanomaterials. In 2010, we 
reported that uncertainties persist about how to evaluate the safety of 
engineered nanomaterials in food and that nanomaterials may enter the 
food supply in certain products generally recognized as safe without 
FDA’s knowledge.
 
18 We also reported in 2010 that EPA has taken a 
variety of actions to better understand and regulate the risks of 
nanomaterials but that the agency faces challenges that might impede its 
ability to regulate nanomaterials effectively.19
                                                                                                                       
16The Organisation for Economic Co-operation and Development is an organization of 34 
national governments, operating by consensus, that fosters dialogue among members to 
discuss, develop, and refine economic and social policies and provides an arena for 
setting rules when multilateral agreements are necessary. 
 For example, we reported 
that the Toxic Substances Control Act gives EPA authority to issue rules 
requiring companies to submit certain information about chemicals. EPA 
recently amended a regulation to require companies to report certain 
information regarding production of chemicals above certain thresholds 
but those thresholds may not capture nanomaterials if they are produced 
in amounts below the thresholds. EPA currently has no plans to further 
reduce the thresholds. In addition, according to officials at CPSC, which is 
charged with protecting the public from unreasonable risks of injury or 
death from thousands of types of consumer products, CPSC does not 
have the statutory authority to require pre-market approval for products, 
including those incorporating nanomaterials. 
17The nanomaterials the Organisation for Economic Co-operation and Development 
selected are fullerenes, single-walled carbon nanotubes, multi-walled carbon nanotubes, 
silver nanoparticles, iron nanoparticles, titanium dioxide, aluminum oxide, cerium oxide, 
zinc oxide, silicon dioxide, dendrimers, nanoclays, and gold nanoparticles. 
18GAO, Food Safety: FDA Should Strengthen Its Oversight of Food Ingredients 
Determined to Be Generally Recognized as Safe (GRAS), GAO-10-246 (Washington, 
D.C.: Feb. 3, 2010). Subsequent to this report, FDA issued draft guidance on April 20, 
2012, on assessing the effects of significant manufacturing changes, including any 
involving nanotechnology, on the identity, safety, or regulatory status of food substances.  
19GAO-10-549. 
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The NNI was codified in law by the 21st Century Nanotechnology 
Research and Development Act in 2003.20
                                                                                                                       
20Pub. L. No. 108-153 (2003). 
 The act requires the President 
to implement a national nanotechnology program and charges the NSTC 
itself—or through a subgroup—with overseeing the planning, 
management, and coordination of the program. The NSTC carries out 
these tasks through the NSET Subcommittee, which includes a co-chair 
from OSTP as well as representatives from the member agencies of the 
NNI. The NSET oversees working groups, including the Nanotechnology 
Environmental and Health Implications (NEHI) working group which 
supports federal activities to protect public health and the environment. 
Figure 1 provides an overview of the organizational structure of the NNI. 
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Figure 1: The NNI Structure 
The NNI does not fund research directly; rather, each of its member 
agencies determines its nanotechnology activities based on its individual 
mission and priorities. The NNI provides a framework for a 
comprehensive nanotechnology research and development program by 
establishing shared goals, priorities, and strategies among member 
agencies; and providing avenues for member agencies to leverage the 
resources of all participating agencies. The four goals of the NNI are to 
(1) advance a world-class nanotechnology research and development 
program; (2) foster the transfer of new technologies into products for 
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commercial and public benefit; (3) develop and sustain educational 
resources, a skilled workforce, and the supporting infrastructure and tools 
to advance nanotechnology; and (4) support responsible development of 
nanotechnology. 
Efforts of the NNI member agencies are reported through triennial 
strategic plans and annual budget supplements. The act directs the 
NSTC, itself or through an appropriate subgroup it designates or 
establishes, to develop and update every 3 years a strategic plan to guide 
the activities of the program. The NSTC published its most recent 
strategic plan in February 2011.21 In addition to the statutorily required 
strategic plan, in 2008, the NSTC published a Strategy for 
Nanotechnology-Related Environmental, Health, and Safety Research 
and updated this document in 2011.22
 
 The EHS strategies published in 
2008 and 2011 expand on the goal of the responsible development of 
nanotechnology by describing the state of science and research needed 
to ensure that nanotechnology provides maximum benefits to the 
environment and human well-being. The act also requires the NSTC to 
prepare an annual report to be submitted to congressional committees on 
the national nanotechnology program’s budget and an analysis of the 
progress made toward achieving the goals and priorities established for 
the program, among other things. In the NNI Supplements to the 
President’s Budget, the NSTC reports overall NNI spending and 
describes research efforts and investments within eight program 
component areas, as seen in table 1. These program component areas 
provide an organizational framework for categorizing the activities of the 
NNI. Data presented in the NNI annual supplements is collected from the 
NNI member agencies by OMB as part of the annual budget formulation 
process. 
                                                                                                                       
21NSTC, Committee on Technology, Subcommittee on Nanoscale Science, Engineering, 
and Technology, National Nanotechnology Initiative Strategic Plan (February 2011). 
22NSTC, Committee on Technology, Subcommittee on Nanoscale Science, Engineering, 
and Technology, National Nanotechnology Initiative Strategy for Nanotechnology-Related 
Environmental, Health, and Safety Research (February 2008) and National 
Nanotechnology Initiative Environmental, Health, and Safety Research Strategy (October 
2011). 
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Table 1: Program Component Areas 
No. Title Description 
1 Fundamental Nanoscale 
Phenomena and Processes 
Discovery and development of fundamental knowledge pertaining to new phenomena in 
the physical, biological, and engineering sciences that occur at the nanoscale. Elucidation 
of scientific and engineering principles related to nanoscale structures, processes, and 
mechanisms. 
2 Nanomaterials Research aimed at the discovery of novel nanoscale and nanostructured materials and at a 
comprehensive understanding of the properties of nanomaterials (ranging across length 
scales, and including interface interactions). Research and development (R&D) leading to 
the ability to design and synthesize, in a controlled manner, nanostructured materials with 
targeted properties. 
3 Nanoscale Devices and Systems R&D that applies the principles of nanoscale science and engineering to create novel, or to 
improve existing, devices and systems. Includes the incorporation of nanoscale or 
nanostructured materials to achieve improved performance or new functionality. To meet 
this definition, the enabling science and technology must be at the nanoscale, but the 
systems and devices themselves are not restricted to that size. 
4 Instrumentation Research, 
Metrology, and Standards for 
Nanotechnology 
R&D pertaining to the tools needed to advance nanotechnology research and 
commercialization, including next-generation instrumentation for characterization, 
measurement, synthesis, and design of materials, structures, devices, and systems. Also 
includes R&D and other activities related to development of standards, including standards 
for nomenclature, materials characterization and testing, and manufacture. 
5 Nanomanufacturing R&D aimed at enabling scaled-up, reliable, and cost-effective manufacturing of nanoscale 
materials, structures, devices, and systems. Includes R&D and integration of ultra-
miniaturized top-down processes and increasingly complex bottom-up or self-assembly 
processes. 
6 Major Research Facilities and 
Instrumentation Acquisition 
Establishment of user facilities, acquisition of major instrumentation, and other activities 
that develop, support, or enhance the nation’s scientific infrastructure for the conduct of 
nanoscale science, engineering, and technology R&D. Includes ongoing operation of user 
facilities and networks. 
7 Environment, Health, and Safety Research primarily directed at understanding the environmental, health, and safety impacts 
of nanotechnology development and corresponding risk assessment, risk management, 
and methods for risk mitigation. 
8 Education and Societal 
Dimensions 
Education-related activities such as development of materials for schools, undergraduate 
programs, technical training, and public communication, including outreach and 
engagement. Research directed at identifying and quantifying the broad implications of 
nanotechnology for society, including social, economic, workforce, educational, ethical, and 
legal implications. 
Source: NSTC, 2011 NNI Strategic Plan. 
 
The act requires triennial external reviews of the national nanotechnology 
program. Specifically, the act requires the NNCO to contract with the 
NRC to conduct the triennial evaluations of the national nanotechnology 
program. The NRC draws on expertise from outside government, 
including from academia, companies, and NGOs. The NRC completed 
reviews in 2002, 2006, and 2009 based on the work of 15 to 23 panelists 
chosen by the NRC and identified in the review. In addition, the NRC also 
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published an independent research strategy to address EHS aspects of 
nanomaterials in 2012.23
The act also requires the President to establish or designate a National 
Nanotechnology Advisory Panel. The advisory panel, by statute, must 
consist primarily of members from academic institutions and industry, and 
panel members must be qualified to provide advice and information on 
nanotechnology research, development, demonstrations, education, 
technology transfer, commercial application, or societal and ethical 
concerns. Since 2004, the President has designated the President’s 
Council of Advisors on Science and Technology (PCAST) to function as 
the advisory panel. PCAST members are generally senior managers in 
major corporations and academia selected for diverse expertise in 
science and technology issues. The advisory panel is required to report 
not less frequently than once every 2 fiscal years on its assessment of the 
national nanotechnology program and recommendations for ways to 
improve the program. The advisory panel has produced three 
assessments to date, in 2005, 2008, and 2010. The first and second 
assessments were authored by a subset of PCAST membership, and the 
third assessment was authored by a working group of three PCAST 
members and additional external experts, but PCAST as a whole 
approved the assessments. The first and second assessments created 
Nanotechnology Technical Advisory Groups, which were comprised of 
approximately 40 members who provided written responses to 
questionnaires developed by PCAST. The membership of these groups is 
not identified in the assessments. The external members of the third 
assessment’s working group were selected by PCAST members and are 
identified in PCAST’s assessment.
 
24
 
 
                                                                                                                       
23NRC, A Research Strategy for Environmental, Health, and Safety Aspects of 
Engineered Nanomaterials (2012). We did not fully evaluate this strategy in the context of 
federal EHS research efforts because it was issued in draft form in January 2012. 
24The working group invited additional experts to speak at public meetings, including 
individuals working in academia and the corporate sector. 
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NSTC reported more than a doubling of funding for nanotechnology EHS 
research by NNI member agencies from fiscal years 2006 to 2010.25
 
 
Reported EHS funding also rose as a percentage of total NNI funding 
during this period, ending up at about 5 percent in 2010. We also 
identified several reporting problems related to the continued absence of 
detailed guidance on how agencies should report funding for their 
nanotechnology research, raising concerns about the quality of EHS 
funding data reported. 
 
From fiscal years 2006 to 2010, NSTC reported more than a doubling of 
NNI member agencies’ funding for nanotechnology EHS research in the 
NNI Supplements to the President’s Budget––from approximately $38 
million26 to $90 million.27
                                                                                                                       
25This includes funding by the seven agencies we selected (CPSC, EPA, FDA, NIH, 
NIOSH, NIST, and NSF) as well as by the other NNI members funding nanotechnology 
EHS research (the Departments of Defense, Energy, and Agriculture). 
 As shown in figure 2, most of this funding was 
reported to be by NSF, NIH, and EPA, and the largest increases in 
reported EHS research funding over this period were at NIH and EPA. 
26Adjusted for inflation, the amount of nanotechnology EHS research funding NSTC 
reported for fiscal year 2006 was approximately $43 million, in 2010 dollars. 
27This includes funding by the seven agencies we selected as well as by the other NNI 
members funding nanotechnology EHS research. 
Funding of EHS 
Research by NNI 
Member Agencies Has 
Increased, but Quality 
of Funding Data Is 
Uncertain 
EHS Research Funding by 
NNI Member Agencies 
More Than Doubled From 
2006 to 2010 and 
Amounted to About 5 
Percent of Total NNI 
Funding in 2010 
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Figure 2: Nanotechnology EHS Research Funding Reported under Program 
Component Area 7 by NSTC for All NNI Member Agencies, Fiscal Years 2006 
through 2010 
Note: This figure does not include research NSTC separately reported as funded by the American 
Recovery and Reinvestment Act of 2009 (Recovery Act) (Pub. L. No. 111-5 (2009)). The Recovery 
Act was enacted to, among other things, preserve and create jobs and promote economic recovery. 
For fiscal year 2009, NSTC reported additional funding for EHS research funded by the Recovery Act, 
as follows: NSF, $3.4 million; NIH, $8.4 million; and Department of Energy, $0.2 million. For fiscal 
year 2010, NSTC did not separately report nanotechnology funding from Recovery Act 
appropriations. 
aThe NNI Supplements to the President’s Budget did not include nanotechnology funding data for 
CPSC and FDA prior to fiscal year 2009. 
 
Figure 3 shows the percentage of NNI funding represented by each 
program component area (PCA) for all NNI member agencies funding 
nanotechnology research. Most of the funding reported was for PCA 1 
(fundamental nanoscale phenomena and processes), PCA 2 
(nanomaterials), and PCA 3 (nanoscale devices and systems). Reported 
EHS funding rose as a percentage of total NNI funding from fiscal years 
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2006 to 2010, ending up at about 5 percent in 2010. Specifically, for fiscal 
year 2010, funding for EHS research was $90 million, while total 2010 
nanotechnology funding was $1.9 billion, as reported in the NNI 
Supplement to the President’s 2012 Budget. 
Figure 3: Percentage of Total NNI Research Funding Represented by Each Program 
Component Area, Fiscal Years 2006 through 2010 
Notes: This figure includes funding by the seven agencies we selected (CPSC, EPA, FDA, NIH, 
NIOSH, NIST, and NSF) as well as by the other NNI member agencies funding nanotechnology 
research (the National Aeronautics and Space Administration and the Departments of Defense, 
Energy, Agriculture, Justice, Homeland Security, and Transportation). 
This figure does not include research NSTC separately reported as funded by the Recovery Act. For 
fiscal year 2009, NSTC reported an additional $511 million for activities funded by the Recovery Act, 
as follows: PCA 1, $131 million; PCA 2, $178 million; PCA 3, $68 million; PCA 4, $12 million; PCA 5, 
$29 million; PCA 6, $73 million; PCA 7, $12 million; and PCA 8, $9 million. For fiscal year 2010, 
NSTC did not separately report agencies’ funding from the Recovery Act appropriations. 
 
 
 
  
 
 
 
Page 18 GAO-12-427  Nanotechnology 
Based on our review of the NNI member agencies’ EHS research funding 
data published by NSTC in the NNI Supplements to the President’s 
Budget and detailed project data we obtained from the seven selected 
agencies for fiscal year 2010, we identified several reporting problems 
that raise concerns about the accuracy, consistency, and completeness 
of funding data reported and make it difficult to assess changes in federal 
funding for nanotechnology EHS research over time. We found that (1) for 
18 percent of 2010 projects reported as EHS research, it was not clear 
that the projects were primarily directed at EHS risks; (2) agencies vary in 
how they report funding for portions of projects that address multiple 
program component areas or include non-nanotechnology research; (3) 
agencies did not always report comparable budget data; and (4) NNI 
does not report updated data after publication of the NNI budget 
supplements, and the reported data may not reflect all EHS funding. 
Of the 236 projects that the seven agencies reported to us as EHS 
research for fiscal year 2010, we determined that, for 43 projects (18 
percent), it was not clear that the projects met the definition for PCA 7—
research primarily directed at the EHS impacts of nanotechnology 
development and corresponding risk assessment, risk management, and 
methods for risk mitigation. As shown in table 2, these projects, 20 of 
which were funded by NSF, accounted for approximately $15 million of 
the reported EHS funding. NSF officials told us that the agency reported 
projects as EHS research if they had some relevance to EHS instead of 
reporting only those projects primarily directed at EHS. 
We also found that, for some projects reported by other agencies, 
studying EHS risks was not the primary purpose of the projects. Instead, 
some projects focused on, for example, exploring how nanotechnology 
could be used in various applications, such as remediation of 
environmental contamination, detection of chemical hazards or 
pathogens, or medical imaging. In addition, some other projects included 
some research relevant to understanding EHS impacts of 
nanotechnology, but it was not clear that the study of EHS issues was the 
primary purpose. For example, some projects studied various 
nanotechnology-enabled drugs, but it was not clear to what extent the 
research was directed at the safety of the drugs versus their efficacy. 
Other projects were directed at instrumentation and nanotechnology 
measurement issues that had some relevance for EHS research, but it 
was not clear whether these should be reported as PCA 7 (EHS 
research) or PCA 4 (instrumentation research, metrology, and standards 
for nanotechnology). 
Reporting Problems Raise 
Concerns about Quality of 
EHS Research Funding 
Data 
Eighteen Percent of Projects 
Reported as EHS Research 
Were Not Clearly Directed at 
EHS Risks 
 
  
 
 
 
Page 19 GAO-12-427  Nanotechnology 
Table 2: GAO Analysis of Nanotechnology Projects Reported by Selected Agencies as EHS Research, Fiscal Year 2010 
   GAO analysis of agencies’ projects 
 Projects seven agencies reported 
to GAO as EHS research   Primarily directed at EHS   
Not clear that projects were 
primarily directed at EHS  
Agency Numbera 
Funding 
(dollars in 
millions)  Number 
Funding  
(dollars in 
millions)  Number 
Funding 
(dollars in 
millions) 
CPSC 8  $0.5   8  $0.5   0  $0  
EPAb 32  17.6c  29 16.9  3 0.8 
FDA 29d 5.3c   20 3.8  9 1.5 
NIH 58 27.7e  55 26.4f  3 1.3g 
NIOSH 49  9.8h  47  9.7   2  0.1  
NIST 11 3.4  5 1.6  6 1.8 
NSF 49 27.1  29 17.1  20 10.0 
Totali 236 $91.4j  193 $76.0  43 $15.5 
Source: GAO analysis of obligations data reported to us by seven agencies. 
Notes: The data shown in this table may differ from that reported by NSTC in the NNI Supplement to 
the President’s 2012 Budget, as described below. 
aFor some projects at NIH, NIOSH, and NIST, we grouped together some of the agencies’ data 
entries and counted them together for the purposes of our analyses. Consequently, the numbers of 
projects reported here may not match the number reported by these agencies elsewhere. Appendix I 
presents more details on how we grouped projects at these agencies. 
bAccording to an EPA official, the total EHS research funding reported to us for fiscal year 2010 
represents actual obligations, but the amounts reported for individual projects are estimates. 
cThe total for this agency differs from that reported by NSTC in the NNI Supplement to the President’s 
2012 Budget because the agency reported its budget authority to OMB for the budget supplement 
and reported obligations to us. 
dFDA reported a total of 30 EHS research projects to us; however, for one of those projects, FDA 
reported that no funds were obligated in fiscal year 2010. Therefore, we excluded that project from 
our analysis. 
eThe total for this agency differs from that reported by NSTC in the NNI Supplement to the President’s 
2012 Budget because NIH included in the data reported to us its fiscal year 2010 obligations of funds 
appropriated by the Recovery Act, which it did not report to OMB for the supplement. 
fWe added $35,044 to NIH’s reported total because we identified additional funding for a subproject 
that we determined should have been included. NIH officials told us that the sub-project was not 
included because the project abstract and other associated text did not contain any of the key words 
for the computerized search of projects that NIH uses to develop its list of EHS research. 
gFor two additional NIH projects, we found that the amount of funding for research primarily directed 
at EHS was overstated. For each of these projects, NIH included the funding for one or more 
subprojects that were not focused on nanotechnology. We included the overstated amounts in the 
dollar value for projects where it was not clear that the research was primarily directed at EHS. 
hThe total for this agency differs from that reported by NSTC in the NNI Supplement to the President’s 
2012 Budget because NIOSH updated its data after initially reporting it to OMB. 
iTotals may not add because of rounding. 
jThe total dollar value of $91.4 million reported to us differs from the total of $90.2 million reported by 
NSTC in the NNI Supplement to the President’s 2012 Budget for two reasons. First, this table 
includes only the seven agencies we reviewed, not all agencies that funded EHS research in 2010. 
Second, four of the seven agencies we reviewed reported data to us that differed from those reported 
by NSTC. 
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As previously noted, we recommended in our 2008 report that the 
Director of OSTP, in consultation with the Directors of NNCO and OMB, 
provide better guidance to agencies on how to report nanotechnology 
EHS research.28 OSTP generally concurred with the report’s findings and 
agreed to review the manner in which agencies respond to the current 
guidance. However, we found that as of February 2012, updated 
guidance had not been issued, and the definition of each program 
component area as documented in OMB Circular A-11 remained the only 
written guidance available to the agencies for reporting their 
nanotechnology EHS research.29
NNCO and FDA officials told us that the reporting of EHS research was a 
regular agenda item at meetings of the NEHI working group during 
development of the 2011 NNI EHS research strategy. However, the 
strategy used information reported via a different OMB data call, one that 
NNCO and OMB officials said was much more detailed and cast a 
broader net than the annual nanotechnology data calls OMB conducts for 
the annual NNI budget supplements (the “crosscut”). The 21st Century 
Nanotechnology Research and Development Act requires annual 
reporting of spending for each program component area, and the crosscut 
collects EHS research funding data based on the definition of PCA 7—
research primarily directed at the EHS impacts of nanotechnology 
 OMB Circular A-11 does not address 
what types of projects should or should not be categorized as EHS 
research, such as how to determine if a project is “primarily” directed at 
EHS impacts or how to report projects focused on environmental or 
health-related applications of nanotechnology. For example, with respect 
to drugs, HHS commented that the Federal Food, Drug, and Cosmetic 
Act requires that both safety and effectiveness be evaluated, in relation to 
one another. As HHS noted, both traits are relevant to the overall health 
impact of a drug product. However, OMB Circular A-11 does not address 
whether funding for research on the effectiveness of nanotechnology-
enabled drugs should be considered nanotechnology EHS research 
under the definition of PCA 7. It also does not address how to report 
EHS-related projects that are focused on instrumentation and metrology, 
and we found that agencies have used different criteria to determine the 
program component area under which to report such projects as well. 
                                                                                                                       
28GAO-08-402. 
29OMB Circular No. A-11, Preparation, Submission, and Execution of the Budget, pt. 2, § 
84 (July 2010). 
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development and corresponding risk assessment, risk management, and 
methods for risk mitigation. However, the data call for the 2011 research 
strategy was, according to OMB’s instructions to agencies, “not limited to 
research and development efforts whose primary purpose is to 
understand and address potential risks to health and to the environment 
posed by this technology—as is called for in the overall crosscut for 
nanotechnology.” Consequently, discussions of how to report projects for 
use in developing the 2011 research strategy do not necessarily provide 
guidance to agencies on how to determine whether their research meets 
the definition of PCA 7, or how to apportion funding for projects that 
address multiple program component areas. 
In our 2008 report, we found that neither NSET nor OMB had provided 
guidance on whether or how to apportion funding for a single research 
project to more than one program component area, if appropriate.30
At NIOSH, agency officials told us that, for projects that include non-
nanotechnology research, they track and report the nanotechnology 
 In this 
review, we found that agencies have different approaches to reporting 
funding for projects that address multiple program component areas or 
include non-nanotechnology research, and the guidance available to the 
agencies—the PCA definitions in OMB Circular A-11—still does not 
address this. We found that, for fiscal year 2010 projects where only a 
portion of the project was focused on nanotechnology EHS research, 
NIST and NSF assigned only a portion of the total funding to PCA 7. At 
NIH, grants or contracts may be either single projects or multiproject 
“parent” grants or contracts, which have multiple individual subprojects. 
According to NIH officials, NIH policy does not allow the funding for a 
single project or subproject to be subdivided across program component 
areas, and NNI policy requires that the individual totals of the program 
component areas sum to the agency’s total nanotechnology funding. As a 
consequence of these two policies, if a grant or contract is a single 
project, then NIH reports the entire value of the individual grant or 
contract in only one program component area. NIH officials told us that if 
a grant or contract has subprojects, NIH reports the funding for an 
individual subproject in only one program component area, but the 
funding for the different subprojects can be reported in different program 
component areas, as applicable. 
                                                                                                                       
30GAO-08-402. 
Agencies Vary in How They 
Report Funding for Portions  
of Projects 
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research portions separately and that the agency reports all of its 
nanotechnology research as EHS because NIOSH’s mission aligns with 
PCA 7. The NIOSH mission includes conducting research on the potential 
implications of nanotechnology on worker health and safety, as well as 
conducting research on potential applications of nanotechnology to solve 
worker health and safety problems. FDA officials also told us that they 
report all of their regulatory science research regarding nanotechnology 
as EHS because it is conducted to support the agency’s mission, which 
they said aligns with PCA 7. As described in FDA’s Strategic Priorities 
document, the agency’s mission includes ensuring both the safety and 
the effectiveness of drugs, biological products, and medical devices, as 
well as the safety of foods and cosmetics.31
Data on nanotechnology funding published in the annual NNI 
Supplements to the President’s Budget are not comparable over time or 
across agencies because the data do not always represent the same type 
of budget information. The NNI budget supplements report funding as 
“actual agency investments” but do not specify what type of data are 
reported as actual agency investments, and until recently, OMB’s 
instructions to agencies for providing these data did not specify what 
should be reported.
 
32 Officials from OMB told us that agencies report 
budget authority for their actual agency investments,33
                                                                                                                       
31FDA, Strategic Priorities 2011-2015. 
 but officials from 
the seven agencies we reviewed generally told us that they had reported 
obligations as their actual agency investments for fiscal years 2006 to 
32OMB’s data calls for 2007 to 2009 actual agency investments did not specify what type 
of budget data should be reported; the data call for 2010 data asked agencies to report 
budget authority for their actual agency investments. 
33Budget authority is authority provided by federal law to enter into financial obligations 
that will result in immediate or future outlays involving federal government funds. Budget 
authority includes (1) appropriations, (2) borrowing authority, (3) contract authority, and (4) 
authority to obligate and expend offsetting receipts and collections. Appropriations 
represent budget authority to incur obligations and make payments from the Treasury for 
specified purposes. Appropriations do not represent cash actually set aside in the 
Treasury for purposes specified in the appropriation act; they represent amounts that 
agencies may obligate during the period of time specified in the respective appropriation 
acts. See GAO, A Glossary of Terms Used in the Federal Budget Process, 
GAO-05-734SP (Washington, D.C.: Sept. 1, 2005). 
Agencies Did Not Always 
Report Comparable Budget 
Data 
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2010.34
Funding data published by NSTC in the NNI Supplements to the 
President’s Budget are not always final because agencies sometimes 
make changes to their data after they are published as actual agency 
investments in the budget supplements. Consequently, outdated data can 
remain available in NNI documents and on the NNI website, which 
publishes nanotechnology research funding data from the budget 
supplements in response to OMB’s 2009 Open Government Directive.
 However, an agency’s budget authority and obligations are not 
always the same amounts in a given year. Furthermore, agencies may 
not always report the same type of budget information from year to year. 
For example, for fiscal year 2009, FDA reported obligations, but then 
reported budget authority for fiscal year 2010 because obligations data 
were not available, according to FDA officials. 
35
                                                                                                                       
34Obligations are definite commitments that create a legal liability of the government for 
the payment of goods and services ordered or received, or a legal duty on the part of the 
United States that could mature into a legal liability by virtue of actions on the part of the 
other party beyond the control of the United States. Payment may be made immediately or 
in the future. An agency incurs an obligation, for example, when it places an order, signs a 
contract, awards a grant, purchases a service, or takes other actions that require the 
government to make payments to the public or from one government account to another. 
See 
 
For example, NIOSH officials told us that their fiscal year 2010 actual 
agency investment in EHS research reported in the NNI Supplement to 
the President’s 2012 Budget was an estimate because the timing of 
OMB’s call for the data was earlier than usual. According to NIOSH 
officials, a second data call occurred later in the fiscal year, at which time 
the agency was able to report an accurate actual funding level. However, 
as of February 2012, NIOSH’s estimated data have not been updated on 
the NNI website. In addition, we found that when NIST reported its 2009 
nanotechnology research funding from the American Recovery and 
Reinvestment Act of 2009 (Recovery Act) ($43.4 million), this was an 
estimate, and the funding was actually obligated over 2 years ($6 million 
obligated in fiscal year 2009, and $37.4 million obligated in fiscal year 
2010). However, as of February 2012, NIST’s estimated data have not 
been updated on the NNI website. 
GAO-05-734SP. 
35As directed in the President’s Memorandum on Transparency and Open Government 
issued on January 21, 2009, OMB issued an Open Government Directive instructing 
executive branch agencies to, among other things, publish government information online. 
NNI Does Not Report Updated 
Data after Publication of 
Budget Supplements, and 
Reported Data May Not Reflect 
All EHS Funding 
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In some instances, the reported data may not reflect all EHS research 
funding. We found that the fiscal year 2010 data reported by NSTC in the 
NNI Supplement to the President’s 2012 Budget did not include all 2010 
nanotechnology funding from Recovery Act appropriations, and OMB did 
not request that information from agencies in its call for 2010 data.36 We 
found that NIH,37 NIST,38 and NSF39 together obligated a total of $131.2 
million for nanotechnology research in 2010 with Recovery Act 
appropriations (including $8 million for EHS research by NIH).40 However, 
while NSF included its Recovery Act funds in the funding reported in the 
NNI Supplement to the President’s 2012 Budget, NIH and NIST did not. 
In addition, some EHS research funding may not be included in the 
budget supplements because of agency-specific reporting methods.41
 
 
                                                                                                                       
36However, the NNI Supplement to the President’s 2011 Budget did include data on 2009 
actual agency investments from Recovery Act appropriations. 
37NIH officials told us that, for fiscal year 2010, NIH obligated funds appropriated by the 
Recovery Act as follows: PCA 1, $19.8 million; PCA 2, $15.6 million; PCA 3, $28.3 million; 
PCA 4, $3.9 million; PCA 7, $8 million; and PCA 8, $0.5 million.    
38NIST officials told us that, for fiscal year 2010, NIST obligated funds appropriated by the 
Recovery Act as follows: PCA 5, $3.1 million; and PCA 6, $34.3 million.  
39NSF officials told us that, for fiscal year 2010, NSF obligated $17.7 million for PCA 6 
research with funds appropriated by the Recovery Act.  
40We did not determine the amounts of 2010 investments from Recovery Act 
appropriations, if any, by the NNI member agencies funding nanotechnology research that 
were not included in this review (the National Aeronautics and Space Administration and 
the Departments of Defense, Energy, Agriculture, Justice, Homeland Security, and 
Transportation).  
41For example, according to NIOSH officials, the agency does not report to OMB funds 
that provide support for major program areas that require shared services and facilities, 
because of the difficulty of placing portions of a central support project into a program 
component area. Also, the automated method NIH uses to compile its list of 
nanotechnology EHS research projects may not identify all appropriate projects because it 
relies on a computerized search of key words, which will not define an absolute dividing 
line between projects that should be included in the EHS program component area and 
those that should not. According to NIH officials, this process provides a consistent, 
reliable, and repeatable method for efficiently scanning NIH’s projects, which number 
more than 50,000 annually. We did not review information on NIH projects that were not 
reported to us by NIH as nanotechnology EHS research. However, in reviewing 
information on the 58 fiscal year 2010 nanotechnology EHS research projects NIH 
reported to us, we identified one example of funding for a subproject that was missed by 
this method.   
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In fiscal year 2010, EHS research at the seven NNI member agencies we 
reviewed focused on two categories of nanomaterials more than others—
metal- and carbon-based nanomaterials, which are used in a variety of 
applications, including electronics, consumer products such as 
sunscreens, medical products, and protective coatings (see fig. 4). NNI 
has not prioritized nanomaterials for EHS research, but in October 2011 it 
outlined criteria for its member agencies to use in doing so. It is not yet 
clear what effect these criteria will have on how agencies prioritize the 
nanomaterials they focus on in their EHS research. 
Figure 4: Categories of Nanomaterials Studied by Seven NNI Member Agencies’ EHS Research Projects, Fiscal Year 2010 
Notes: The figure is based upon our analysis of the 193 projects we determined were primarily 
directed at EHS. It does not include the 43 projects for which it was not clear to us that the research 
was primarily directed at EHS. The numbers of projects shown do not total 193 because projects 
often targeted more than one category of nanomaterials. 
aMetal-based nanomaterials consisted of silver, gold, iron-based nanomaterials, various metal oxides 
(titanium, zinc, cerium, and aluminum oxides), and other metal-based nanomaterials. 
bCarbon-based nanomaterials consisted of carbon nanotubes, fullerenes, and other carbon-based 
nanomaterials. Spherical and ellipsoidal carbon nanomaterials are referred to as fullerenes, while 
cylindrical ones are called nanotubes. 
cSemiconductor-based nanomaterials consisted of quantum dots, silicon-based nanomaterials, and 
other semiconductor-based nanomaterials. Quantum dots are closely packed semiconductor crystals 
composed of hundreds or thousands of atoms. 
dExamples of projects not targeted to particular nanomaterials are projects that funded large research 
centers on the environmental implications of nanotechnology, or projects that purchased data on the 
market for nanomaterials in order to guide exposure assessment studies by providing information on 
potential consumer exposures. 
eOrganic nanomaterials consisted of dendrimers, other polymers, and other organic-based 
nanomaterials. Dendrimers are branched nanosized polymers. The surface of a dendrimer has 
numerous chain ends, which can be tailored to perform specific chemical functions. 
fOther nanomaterials consisted solely of nanoclays (one project). 
 
 
EHS Research 
Funded in 2010 
Focused On Metal- 
and Carbon-Based 
Nanomaterials 
 
  
 
 
 
Page 26 GAO-12-427  Nanotechnology 
As shown in figure 5, we found that in the 193 fiscal year 2010 research 
projects we determined were primarily directed at EHS, the nanomaterials 
that were most frequently the focus of this research were carbon 
nanotubes (70 projects), nanosilver (60 projects), and nanoscale titanium 
dioxide (48 projects).42
• Carbon nanotubes are nanoscale cylinders consisting of seamlessly 
“rolled” sheets of graphene, a form of carbon. They are extraordinarily 
strong, flexible, lightweight, heat resistant, and have high electrical 
conductivity. Carbon nanotubes are currently used in a variety of 
applications including conductive coatings for touchscreens and solar 
cells, and sporting goods such as bicycle frames and baseball bats. 
According to a 2009 NIOSH report, carbon nanotubes have been 
shown to produce adverse effects in the respiratory systems of rats.
 
43
• Nanosilver is a metal-based nanomaterial that, according to a 2010 
EPA report, is currently used in an increasing number of consumer 
and medical products because of its remarkably strong antimicrobial 
properties.
 
44
                                                                                                                       
42The numbers of projects do not total 193 because (1) some projects targeted 
nanomaterials other than carbon nanotubes, nanosilver, and nanoscale titanium dioxide; 
(2) projects often targeted multiple nanomaterials; and (3) nineteen of the 193 projects 
were not targeted to particular nanomaterials. For example, some projects not targeted to 
particular nanomaterials funded large research centers on the environmental implications 
of nanotechnology; others purchased data on the market for nanomaterials to guide the 
agency’s exposure assessment studies by providing information on the potential 
consumer exposures.  
 For example, EPA reported that nanosilver is being 
incorporated into clothing, food contact materials such as packaging 
and cutting boards, household appliances, cosmetics, and children’s 
toys. It is also used in industrial processes because of its ability to 
catalyze many reactions. According to EPA’s 2010 report, there is 
clear evidence that nanosilver is toxic to aquatic and terrestrial 
organisms and may be detrimental to human health. In this report, 
EPA noted that several studies have shown that nanosilver can be 
released into the wastewater stream during washing, such as from 
socks containing nanosilver. The nanosilver released may disrupt the 
43NIOSH, Approaches to Safe Nanotechnology: Managing the Health and Safety 
Concerns Associated with Engineered Nanomaterials, Department of Health and Human 
Services (NIOSH) Publication No. 2009–125 (March 2009). 
44EPA, State of the Science Literature Review: Everything Nanosilver and More, 
EPA/600/R-10/084 (August 2010). 
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helpful bacteria used in wastewater treatment processes or be 
released into the environment. 
• Nanoscale titanium dioxide is a metal-based nanomaterial used in 
sunscreens, protective coatings, and other materials to manage heat 
and light by blocking UV light from the sun’s rays. It is also being 
added to paints, cements, windows, tiles, and other products for its 
sterilizing and deodorizing properties and is being used for antifogging 
coatings and self-cleaning windows. In addition, it is being 
investigated for use in removing contaminants from drinking water. 
According to a 2011 NIOSH report, nanoscale titanium dioxide is a 
potential occupational carcinogen when inhaled.45 Regarding 
exposure to this nanomaterial in sunscreens, a 2010 FDA publication 
found that nanoscale titanium dioxide included in a formulation similar 
to currently marketed sunscreens is unlikely to significantly penetrate 
human skin.46
                                                                                                                       
45NIOSH, Current Intelligence Bulletin 63: Occupational Exposure to Titanium Dioxide, 
Department of Health and Human Services (NIOSH) Publication No. 2011–160  
(April 2011).  
 
46N. Sadrieh, A.M. Wokovich, N.V. Gopee, J. Zheng, D. Haines, D. Parmiter, P.H. 
Siitonen, C.R. Cozart, A.K. Patri, S.E. McNeil, P.C. Howard, W.H. Doub, L.F. Buhse, 
“Lack of Significant Dermal Penetration of Titanium Dioxide from Sunscreen Formulations 
Containing Nano- and Sub-Micron-Size TiO2 Particles,” Toxicological Sciences, vol. 115, 
no. 1 (2010):156-66. 
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Figure 5: Nanomaterials Studied by Seven NNI Member Agencies’ EHS Research Projects, Fiscal Year 2010 
Notes: The figure is based upon our analysis of the 193 projects we determined were primarily 
directed at EHS. It does not include the 43 projects for which it was not clear to us that the research 
was primarily directed at EHS, nor those not targeted to particular nanomaterials. The numbers of 
projects shown do not total 193 because projects often targeted more than one nanomaterial. 
aOf the 52 projects that targeted titanium oxides, at least 48 projects studied titanium dioxide. Two 
projects studied titanium oxides, but it was not clear if these included titanium dioxide. 
bOther metal-based nanomaterials consisted of various metals, such as cobalt, copper, magnesium, 
manganese, nickel, and others, as well as some composites of multiple metals. 
cOther carbon-based nanomaterials consisted of carbon nanofibers, carbon nanowires, carbon 
nanohorns, carbon black, diamond, graphene, nanoscale graphene platelets, plastic composite 
material containing carbon nanofibers, and soot nanoparticle agglomerates. 
dOther polymers consisted of polystyrene, polyhedral oligomeric silsesquioxanes, nylon 6 nanofibers, 
plastics, polymeric nanovesicles, and poly(propargyl glycolid) nanoparticles. 
eOther organic-based nanomaterials consisted of flourescein, sucrose, and dioctyl phthalate particles. 
fOther semiconductor-based nanomaterials consisted of selenium nanoparticles and cadmium and 
lead selenides/sulfides. 
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NNI has not prioritized nanomaterials for EHS research, but the 2011 NNI 
EHS research strategy outlines criteria to assist its member agencies in 
doing so. The main criteria NNI proposed are the extent to which (1) 
study of a particular nanomaterial may provide a major contribution to the 
research knowledge base, and (2) nanomaterials and nanotechnology-
enabled products may pose a safety concern to workers, consumers, and 
the environment. NNI further identified five criteria for assessing whether 
a material may pose a safety concern: (1) the nanomaterial’s potential for 
hazard, (2) likelihood of exposure, (3) high reactivity, (4) biological 
novelty, and (5) the involvement of the material in an event that produced 
health or environmental impacts. However, because the criteria were 
published in October 2011, it is too soon to tell how they will influence 
NNI member agencies’ decisions about which nanomaterials to prioritize. 
Furthermore, it is unclear if the information needed to use the NNI criteria 
is available. As we reported in May 2010, predicting and assessing the 
potential hazards, exposures, and resulting risks from nanomaterials is 
difficult, and current understanding of nanomaterial toxicity and exposure 
is limited. For example, the findings from completed toxicity studies of a 
nanomaterial constructed in one manner may not be applicable to 
understanding the risks posed by the same nanomaterial constructed in a 
different manner and, therefore, studies of similar nanomaterials may not 
be comparable.47 Also, according to the NRC’s 2012 draft strategy for 
nanotechnology EHS research, there is incomplete information on the 
effects of the array of nanomaterials used in products and a lack of 
information on effects of chronic exposures. NRC reported that most 
toxicity studies test a single material and usually focus on effects of acute 
exposures.48
In addition, reliable, comprehensive information is not readily available on 
the likelihood of exposure to nanomaterials. Consumers and workers are 
more likely to be exposed to nanomaterials that are already produced in 
large quantities or incorporated into a larger number of products, but 
information on the prevalence or production volumes of nanomaterials or 
nanotechnology-enabled products is currently limited. As previously noted 
in this report, FDA, CPSC, and EPA may not receive complete 
 
                                                                                                                       
47GAO-10-549. 
48NRC, A Research Strategy for Environmental, Health, and Safety Aspects of 
Engineered Nanomaterials (2012). 
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information on what nanomaterials are already in use in the case of 
certain products. CPSC officials told us that one way the agency collects 
information on the use of nanomaterials in products to better understand 
potential exposures is by purchasing information from commercial 
vendors. However, we found that obtaining such information from 
commercial vendors such as market research companies can be costly, 
and it is difficult to assess the reliability of such research because it can 
involve data and methods, including modeling based on various 
assumptions, that may be proprietary. 
Another source of information on nanomaterials in commerce is the 
Woodrow Wilson International Center for Scholars’ Project on Emerging 
Nanotechnologies, which maintains an inventory of nanotechnology-
based products.49 As of the March 2011 update to the list, the inventory 
contained approximately 1,300 nanotechnology-based products. 
However, the Wilson Center’s list is not comprehensive, and it consists of 
consumer products.50 As we reported in May 2010, occupational 
exposure is a particular concern because the exposure and risk to 
workers is potentially greater than the risk to consumers.51
 
 At present, 
though, there is little information on the exposure of workers to 
nanomaterials in the workplace. 
                                                                                                                       
49The Wilson Center is a nonpartisan research institution established by an act of 
Congress in 1968 and supported by public and private funds. The Project on Emerging 
Nanotechnologies was established in April 2005 as a partnership between the Wilson 
Center and the Pew Charitable Trusts. The project’s mission is to, among other things, 
collaborate with researchers, government, industry, and others to identify gaps in 
knowledge and regulatory processes, develop strategies for closing them, and provide 
independent, objective knowledge and analysis related to the development and 
commercialization of nanotechnologies. 
50According to the Wilson Center, the inventory is based on information that can be readily 
found on the Internet about products that (1) can be readily purchased by consumers and 
(2) are identified as nanotechnology-based by the manufacturer or another source. The 
center tried to avoid including products that clearly do not use nanotechnology, but they 
did not verify manufacturers’ claims or conduct any independent testing of products. 
51GAO-10-549. 
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The NNI member agencies have collaborated extensively with each other 
and nonfederal stakeholders on EHS research and strategies. The NNI 
member agencies participated in interagency efforts to develop joint 
strategies related to EHS research. They have also undertaken over 40 
collaborative nanotechnology EHS research projects in recent years, 
signing agreements with both federal and nonfederal stakeholders. Many 
of the nonfederal stakeholders responding to our questionnaire rated their 
collaborative activities with NNI agencies as very or generally useful, 
although they have identified some challenges. 
 
NNI member agencies have collaborated through the NSTC to develop 
joint EHS research strategies. The NSTC primarily coordinates 
nanotechnology EHS research through the NSET Subcommittee and the 
NEHI, an interagency working group. The NEHI’s purpose includes 
providing for an exchange of information among agencies and with 
nonfederal stakeholders; facilitating the identification, prioritization, and 
implementation of nanotechnology EHS research; and managing the EHS 
interagency research strategy and facilitating its implementation. The 
2011 NNI EHS research strategy was developed by NNI member 
agencies working through the NEHI working group. The strategy sets a 
common vision for nanotechnology EHS research, EHS research 
categories and needs, and key principles intended to assist the NNI 
member agencies make strategic decisions about research programs that 
will advance the NNI EHS research agenda while meeting their respective 
missions. According to several NNI member agency officials, individual 
agencies’ implementation efforts of the 2011 NNI EHS research strategy 
are discussed at NEHI meetings. However, since the strategy was 
finalized in October 2011, it is too soon to tell to what extent it will be used 
to integrate the NNI member agencies’ implementation plans. The 2011 
NNI EHS research strategy updated and replaced the 2008 NNI Strategy 
for Nanotechnology-Related EHS Research, which had established 
common priority EHS research needs. The 2008 NNI Strategy for 
Nanotechnology-Related EHS Research was also developed by the NEHI 
working group and informed by earlier publications of NNI EHS research 
needs. 
Officials from five of the NNI member agencies told us that they use the 
NEHI working group as a forum to collaborate on nanotechnology EHS 
research projects. For example, CPSC officials told us that they identify 
agencies with expertise on testing nanomaterials found in consumer 
products through discussions in the NSET Subcommittee and NEHI 
working group, which has led to collaborative testing of exposure and 
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release of selected nanomaterials. This collaboration has resulted in data 
that support the respective missions of the collaborative agencies. 
Officials from the National Toxicology Program at NIH noted that they 
selected nanomaterials for study based in part on discussions in the NEHI 
working group and NNI sponsored workshops. Officials from NIST told us 
that NNI member agencies are also working through the NEHI working 
group to develop an inventory of collaborative EHS research activities. 
Collaborative activities related to EHS research have been reported in the 
2011 NNI EHS research strategy and annual NNI Supplements to the 
President’s Budget. 
 
The NNI member agencies have recently initiated numerous 
nanotechnology EHS research projects in collaboration with other federal 
agencies and nonfederal stakeholders. We reviewed formal collaborative 
nanotechnology EHS research projects initiated from February 2008 to 
October 2011, while the 2008 NNI Strategy for Nanotechnology-Related 
EHS Research was in effect. The 2008 NNI Strategy for Nanotechnology-
Related EHS Research called for the NEHI and the NNI member 
agencies to coordinate agency efforts to address priority research needs 
and, among others, identify opportunities for collaboration and joint 
development and use of resources where appropriate, facilitate 
partnerships with industry, and coordinate and support international 
efforts, support development of consensus-based standards, and 
facilitate wide dissemination of research results and other nonproprietary 
EHS information. During this period, NNI member agencies initiated 43 
formal collaborative projects related to EHS research––24 interagency 
collaborations and 19 collaborations that included nonfederal 
stakeholders. Most of the interagency collaborations were among the NNI 
member agencies included in our review, but a few were with other 
federal agencies such as the Department of Defense, the Department of 
Labor’s Occupational Safety and Health Administration, and the 
Department of Agriculture. Nonfederal stakeholders included foreign 
governments, such as the United Kingdom (UK) and China; universities, 
such as the University of Massachusetts, Lowell and Rice University; and 
NGOs, such as the International Alliance for NanoEHS Harmonization 
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(IANH) and the International Life Sciences Institute Research 
Foundation.52
NNI member agencies used these collaborative projects to extend their 
capability to achieve their individual missions. For example, CPSC 
collaborated with four agencies to conduct research on nanomaterials 
found in consumer products. NIOSH, an agency within the Centers for 
Disease Control and Prevention that conducts research and makes 
recommendations for the prevention of work-related injury and illness, 
partnered with entities that operate nanomanufacturing facilities to better 
understand the potential for occupational exposure to nanomaterials. 
NIST, which aims to advance measurement science, standards, and 
technology, signed an agreement with the IANH to jointly create protocols 
for toxicological tests of selected representative nanoparticles, confirming 
inter-laboratory reproducibility and verifying the predictability of certain 
procedures. 
 
Collaborative EHS research projects have resulted in transfers of funding 
as well as sharing of expertise, facilities, and other resources, as shown 
in the following examples: 
• An interagency agreement between CPSC and NIOSH to study the 
pulmonary effects of titanium dioxide nanoparticles released from 
aerosol spray products involved CPSC providing the product to be 
tested and transferring funding to NIOSH to construct the testing 
equipment, with NIOSH providing expertise and staff time to run the 
tests and produce a report. 
• An agreement among the NIH’s National Cancer Institute, the 
National Institute of Environmental Health Sciences (NIEHS), and the 
National Institute of Biomedical Imaging and Bioengineering to 
develop, maintain, and operate a web-based nanomaterial registry 
specified that the National Institute of Biomedical Imaging and 
Bioengineering will develop the registry to provide consistent and 
curated information on the biological and environmental interactions of 
                                                                                                                       
52The IANH is a group of internationally recognized experts who have agreed to develop 
specific tools and testing protocols and perform a set of round robin experiments for 
reproducible testing of nanomaterial biological interactions and toxicology. The 
International Life Sciences Institute Research Foundation is a nonprofit organization 
based in Washington, D.C., that focuses on advancing the methods and application of 
science in risk assessment, human nutrition, and the prevention of obesity. 
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well-characterized nanomaterials, as well as links to associated 
publications, modeling tools, computational results, and 
manufacturing guidance from existing databases. The National 
Cancer Institute and the NIEHS provided funding. NIEHS also 
committed to provide input to the constitution of an advisory board 
and attend its meetings, as well as be represented in the nano registry 
project management team. 
• Agencies have also issued joint solicitations for grant applications, 
such as one between EPA and a number of UK agencies to solicit 
proposals for research on environmental and health implications of 
nanotechnology. EPA and the UK agencies signed an agreement that 
notes (1) the funding of grants will be made consistent with the budget 
priorities of each party and (2) they are to work jointly to define the 
scientific priorities, issue the request, assist with peer review and 
selection of grantees, and disseminate the research results. 
Details on these and other collaborative EHS research projects are 
provided in appendix II. 
 
The 138 nonfederal stakeholders who responded to our questionnaire 
reported that they benefited from collaboration with NNI member 
agencies but faced some challenges. Most respondents indicated that the 
2011 NNI EHS research strategy was very or somewhat effective at 
addressing the EHS research needs. Respondents reported that they 
also obtained information on nanotechnology EHS risks from NNI 
member agencies and nongovernmental sources. 
The following three formal mechanisms for collaboration with NNI 
member agencies were most frequently identified by respondents as 
generally or very useful to them: (1) joint data gathering and sharing; (2) 
joint research solicitations or funding of research consortia; and (3) 
competitive grants. See figure 6 for respondents’ ratings of seven formal 
collaborative mechanisms we identified for them to rate. Some 
respondents who provided comments in response to optional open-ended 
questions also identified public-private partnerships, such as joint 
academic, government, and industry information exchange and research 
programs, as collaboration mechanisms the NNI member agencies 
should consider. A few respondents who commented in response to 
optional open-ended questions also cited benefits to informal 
collaboration with NNI agencies, such as discussions during workshops 
and conferences. 
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Figure 6: Usefulness of Formal Collaboration Mechanisms for Nanotechnology EHS Research, According to Questionnaire 
Respondents 
Note: Excludes respondents who selected “No basis to judge” and those who did not check a 
response. 
 
Since both the 2011 NNI EHS research strategy and its predecessor, the 
2008 NNI Strategy for Nanotechnology-Related EHS Research, called for 
partnerships with industry and other nonfederal stakeholders, we included 
questions about collaboration with NNI member agencies in our 
questionnaire. When asked about the usefulness of their collaboration 
with the NNI member agencies, more than half of respondents rated their 
collaborative EHS research or related activities for each of the NNI 
member agencies as generally or very useful, as seen in figure 7. 
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Figure 7: Usefulness of Collaborative EHS Research or Related Activities with NNI 
Member Agencies, According to Questionnaire Respondents 
Note: Excludes respondents who selected “No basis to judge” and those who did not check a 
response. 
 
Stakeholders responding to our questionnaire indicated that certain 
challenges to collaboration with NNI member agencies we identified on 
EHS research apply to them. As seen in figure 8, more than two-thirds of 
those who rated the challenge of lack of funding and the challenge of 
limited awareness of collaboration opportunities indicated that each of 
these challenges apply to them. This is consistent with what we heard 
from representatives of a nanotechnology trade association and an NGO, 
who stated that there is limited funding for corporate EHS research and 
development efforts because they do not generate revenues. Some 
respondents who provided comments in response to optional open-ended 
questions stated that the private sector needs government funding for 
EHS research. A number of respondents also commented that 
government funding for EHS research was inadequate or an “after-
thought” to other purposes. Some respondents also commented that 
funding seems to be targeted toward large, multiyear centers rather than 
smaller targeted projects that can help address near-term EHS needs. 
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More than half of those responding noted that each of the challenges of 
regulatory uncertainty, lack of standardization—such as different 
terminology or protocols—and concerns regarding disclosure of 
proprietary or confidential business information, apply to them. Some 
respondents cited regulatory uncertainty—that is, lack of a clear 
regulatory environment to enable commercialization and protect 
consumers and the general public—as a challenge to collaboration with 
their work with NNI member agencies on nanotechnology EHS research. 
For example, a number of respondents who provided comments in 
response to optional open-ended questions pointed to regulatory 
uncertainty as limiting the ability of companies to determine their EHS 
responsibilities. Some respondents also commented on difficulties in 
collaborating with NNI member agencies resulting from differences in 
expertise and regulatory approaches across different government 
agencies or even within the same agency. With regard to lack of 
standardization as a challenge to collaboration on nanotechnology EHS 
research, some respondents provided examples related to the lack of 
scientific consensus on the definition of nanomaterials, the testing 
methods for toxicology research, and common terminology across 
research and regulatory agencies. 
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Figure 8: Challenges to Collaboration on Nanotechnology EHS Research, 
According to Questionnaire Respondents 
Note: Excludes respondents who selected “Don’t know/Not sure” and those who did not check a 
response. 
 
When asked to rate the effectiveness of mechanisms we identified that 
NNI member agencies can use for obtaining input from nonfederal 
stakeholders on the development of the NNI EHS research strategies, 
respondents most frequently identified the following three mechanisms as 
being used somewhat effectively or effectively: (1) workshops, 
conferences, and other public speaking engagements; (2) advisory 
councils; and (3) the NNI web portal. 
Most Respondents to Our 
Questionnaire Rated the 2011 
NNI EHS Research Strategy as 
Somewhat or Very Effective 
 
  
 
 
 
Page 39 GAO-12-427  Nanotechnology 
Figure 9: Effectiveness of Mechanisms for Obtaining Input on the NNI Strategic Planning for EHS Research, According to 
Questionnaire Respondents 
Note: Excludes respondents who selected “No basis to judge” and those who did not check a 
response. 
 
When asked to rate the 2011 NNI EHS research strategy, most of those 
responding rated this strategy as somewhat or very effective at 
addressing nanotechnology EHS research needs. As seen in figure 10, 
while just over half of those responding to these questions indicated the 
2008 NNI Strategy for Nanotechnology-Related EHS Research 
addressed these needs somewhat or very effectively, 79 out of 98 
indicated the 2011 NNI EHS research strategy addressed these needs 
somewhat or very effectively.53
                                                                                                                       
53The NSTC finalized the 2011 NNI EHS research strategy while the questionnaire was 
being completed by respondents. Therefore, some respondents may have rated the draft 
2011 NNI EHS research strategy while others may have rated the final version.  
 Some of the respondents who commented 
in response to optional open-ended questions commended the 2011 NNI 
EHS research strategy for accurately capturing the input of the 
workshops’ participants and summarizing the research needs, but others 
pointed to shortcomings, including a lack of prioritization and insufficient 
focus on implementation. For example, one respondent commented that 
the strategy would only be effective if it was implemented, and that it may 
not be sufficient to rely on the agencies’ voluntary implementation efforts. 
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Figure 10: Effectiveness of NNI EHS Research Strategies at Addressing Nanotechnology EHS Research Needs, According to 
Questionnaire Respondents 
Note: Excludes respondents who selected “No basis to judge” and those who did not check a 
response. 
 
Additionally, respondents identified various sources, including the NNI 
member agencies, from which they obtained information on the potential 
EHS risks of nanotechnology. When asked to estimate the frequency with 
which they obtained nanotechnology EHS information from NNI member 
agencies in recent years, respondents reported obtaining information 
from the NNI member agencies in varying frequencies. More than half of 
the respondents to these questions reported occasionally or often 
obtaining information from EPA and NIOSH, as seen in figure 11. 
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Figure 11: Frequency with Which Questionnaire Respondents Reported Obtaining 
Information on the Potential EHS Risks of Nanotechnology from NNI Member 
Agencies 
Note: Excludes respondents who selected “Don’t know/Not sure” and those who did not check a 
response. 
 
The 2011 NNI strategic plan calls for providing a “one-stop” Internet-
based portal for nanotechnology information, including, among other 
things, scientific data such as characterization and toxicity 
measurements. About 80 percent of the 131 stakeholders responding to a 
question about how useful such a portal would be indicated that an 
Internet-based portal for nanotechnology EHS information would be 
generally or very useful to them. The NNI does not currently provide a 
portal that contains this information, but an NNCO official told us that the 
NNCO is implementing a web-based map that identifies the 
instrumentation and facilities for nanotechnology research at major 
universities and centers in the U.S. and federal labs. 
When asked to rate the frequency with which they obtained information 
on the potential EHS risks of nanotechnology from nongovernmental 
sources, as seen in figure 12, more than two-thirds of respondents 
reported that they occasionally or often obtained information from each of 
the following four sources: (1) peer-reviewed scientific publications; (2) in-
house research; (3) online databases; and (4) news outlets. 
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Figure 12: Frequency with Which Questionnaire Respondents Reported Obtaining Information on the Potential EHS Risks of 
Nanotechnology from Nongovernmental Sources 
Note: Excludes respondents who selected “Don’t know/Not sure” and those who did not check a 
response. 
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NNI strategy documents address two and partially address four of the six 
desirable characteristics of effective national strategies that we identified 
in prior work and that offer policymakers and implementing agencies a 
management tool that can help ensure accountability and more effective 
results. The three NNI strategy documents––the 2011 NNI strategic plan, 
the 2011 NNI EHS research strategy, and the NNI Supplement to the 
President’s 2012 Budget54
We rated the NNI strategy documents to determine how well they jointly 
addressed the six characteristics that we have identified for effective 
national strategies, as described in table 3. 
––compose a national strategy for 
nanotechnology EHS research and create a framework for achieving NNI 
program goals and priorities. 
Table 3: Summary of Desirable Characteristics for a National Strategy 
Desirable characteristic Brief description 
Purpose, scope, and 
methodology  
Addresses why the strategy was produced, the scope 
of its coverage, and the process by which it was 
developed.  
Problem definition and risk 
assessment  
Addresses the particular national problems and 
threats the strategy is directed toward.  
Goals, subordinate objectives, 
activities, and performance 
measures  
Addresses what the strategy is trying to achieve; 
steps to achieve those results; as well as the 
priorities, milestones, and performance measures to 
gauge results.  
Resources, investments, and 
risk management  
Addresses what the strategy will cost, the sources 
and types of resources and investments needed, and 
where resources and investments should be targeted 
by balancing risk reductions and costs.  
Organizational roles, 
responsibilities, and 
coordination  
Addresses who will be implementing the strategy, 
what their roles will be compared to others, and 
mechanisms for them to coordinate their efforts.  
Integration and implementation  Addresses how a national strategy relates to other 
strategies’ goals, objectives, and activities—and to 
subordinate levels of government and their plans to 
implement the strategy.  
Source: GAO-04-408T. 
                                                                                                                       
54NSTC, Committee on Technology, Subcommittee on Nanoscale Science, Engineering, 
and Technology, National Nanotechnology Initiative Environmental, Health, and Safety 
Research Strategy (October 2011); National Nanotechnology Initiative Strategic Plan 
(February 2011); and The National Nanotechnology Initiative Supplement to the 
President’s 2012 Budget (February 2011). 
NNI Strategy 
Documents Address 
or Partially Address 
Desirable 
Characteristics of 
National Strategies 
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Ideally, effective national strategies should fully address all of these 
characteristics. However, we recognize that by their nature, national 
strategies are intended to provide broad direction and guidance—rather 
than be prescriptive, detailed mandates—to the relevant implementing 
agencies. Thus it is unrealistic to expect all national strategies to provide 
details on each and every characteristic we identified. Moreover, the NNI 
member agencies have different statutory authority and functions that 
may significantly affect their research and research priorities. 
Nonetheless, we believe the more detail a strategy provides, the easier it 
is for the responsible parties to implement it and achieve its goals. 
We reviewed the three NNI strategy documents for elements related to 
these characteristics, and based on the inclusion of these elements, rated 
how well the strategic documents address the six characteristics. 
According to our methodology, the strategy documents “address” a 
characteristic when they explicitly include all, or nearly all, elements of the 
characteristic and have sufficient specificity and detail. The documents 
“partially address” a characteristic when they include some or most of the 
elements of the characteristic with sufficient specificity and detail.55
As described in table 4, we found, when reviewed as a whole, that the 
strategy documents address or partially address all of the desirable 
characteristics of a national strategy. 
 The 
documents “do not address” a characteristic when they do not include any 
elements of a characteristic or references are too vague or general to be 
useful. Additional details about our ratings and the elements that make up 
these characteristics are available in appendix I. 
 
 
                                                                                                                       
55The “partially addresses” category includes a range that varies from explicitly citing most 
of the elements to citing as few as one of the elements of a characteristic. Yet because 
the three NNI documents have different purposes and audiences an individual document 
need not address each desirable national strategy characteristic. However, areas not 
addressed in one document should be more fully developed in another. 
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Table 4: Extent NNI Strategy Documents Address GAO’s Desirable Characteristics 
with Respect to Nanotechnology EHS Research 
Desirable characteristic Address 
Partially 
address Do not address 
1) Purpose, scope, and methodology X   
2) Problem definition and risk 
assessment 
X   
3) Goals, subordinate objectives, 
activities, and performance 
measures 
 X  
4) Resources, investments, and risk 
management 
 X  
5) Organizational roles, responsibilities, 
and coordination 
 X  
6) Integration and implementation  X  
Source: GAO analysis of the NNI strategy documents. 
 
Taken as a whole, the NNI strategy documents address the first two 
characteristics—purpose, scope, and methodology and problem definition 
and risk assessment—by including all, or nearly all, of their elements. 
These characteristics describe the scope of the strategy, describe how 
and why it was produced, define the problems the strategy intends to 
address, discuss causes and the operating environment, and provide a 
risk assessment or broad description of potential risks. Elements of these 
characteristics that are included in the documents are providing a clear 
statement of purpose, defining key terms, delineating what major 
functions or mission areas are covered, discussing problems with the 
current understanding of EHS implications of nanotechnology, and the 
quality of currently available data, among others. 
The NNI strategy documents partially address the third characteristic 
regarding goals, subordinate objectives, activities, and performance 
measures. This characteristic describes the overall desired results, 
hierarchy of strategic goals and subordinate objectives, priorities, 
milestones, outcome-related performance measures, and process for 
monitoring and reporting on progress, among others. The NNI strategy 
documents include a number of elements such as desired results, 
strategic goals, and subordinate objectives, but do not include, or do not 
fully develop, other elements such as priorities, milestones, or outcome-
related performance measures. Performance information—such as 
outcome-related performance measures and milestones comprised of 
targets and time frames for meeting those measures—allows managers 
Purpose, Scope, and 
Methodology and Problem 
Definition and Risk Assessment 
(Desirable Characteristics  
1 and 2) 
Goals, Subordinate Objectives, 
Activities, and Performance 
Measures (Desirable 
Characteristic 3) 
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to identify performance problems and develop approaches that improve 
results. For the purposes of this report, we define performance 
information to mean data collected to measure progress toward achieving 
an established goal. A wide range of information can be relevant to 
program performance. Performance information can focus on various 
dimensions of performance such as outcomes, outputs, quality, 
timeliness, customer satisfaction, or efficiency. It can inform key 
management decisions such as setting program priorities, allocating 
resources, identifying program problems, and taking corrective action to 
solve those problems; or it can help determine progress in meeting the 
goals of programs or operations. The NNI strategy documents contain 
detailed research needs for nanotechnology EHS and report the annual 
funding of EHS research and the number of projects supported for 
selected years, but the documents do not prioritize among these needs or 
include outcome-related performance measures, targets, or time frames 
that allow for monitoring and reporting on progress toward meeting the 
research needs. 
Independent reviews of the prior NNI strategy documents also noted an 
absence of performance information. In 2010, the National 
Nanotechnology Advisory Panel recommended that the NNCO monitor 
metrics that assess, among other things, the NNI’s progress on 
developing methodologies to assess plausible risks of nanotechnology. 
The advisory panel also recommended that the NEHI working group 
develop and implement a strategy that links EHS research activities with 
knowledge gaps and decision-making needs. The 2009 NRC review 
concluded that the 2008 NNI Strategy for Nanotechnology-Related EHS 
Research could be an effective tool, but did not include a number of 
elements, including measures of research progress. We previously 
reported that, ideally, a national strategy would set clear desired results 
and priorities, outcome-related performance measures, and specific 
milestones while giving implementing parties flexibility to pursue and 
achieve those results within a reasonable time frame.56
The NNI strategy documents give agencies wide latitude to develop 
research programs to meet the goals and research needs of the NNI, but 
we found that NNI member agencies vary in their identification and 
reporting of agency-specific performance information for nanotechnology 
 
                                                                                                                       
56GAO-04-408T. 
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EHS research that could align with the NNI research needs. The 2011 
NNI EHS research strategy states that prioritization, timing, and staging of 
the research needs identified by the strategy are components of an 
implementation plan and should be developed within agency missions 
and appropriations. Similarly, the 2011 NNI strategic plan states that the 
document serves as a guide for individual agency implementation. Six of 
the seven NNI agencies we reviewed have documented performance 
measures, targets, or time frames for their EHS research. Three of the 
NNI member agencies—CPSC, FDA, and NIH—annually report EHS-
related performance information through their publicly available annual 
performance reports.57 Three other NNI member agencies—EPA, NIOSH, 
and NIST—identify strategic goals and performance measures and 
targets in their program-level nanotechnology EHS strategies, but have 
not collected, or have not publically reported results of these performance 
measures.58
The NNI strategy documents partially address the fourth and fifth 
characteristics describing resources, investments, and risk management 
and organizational roles, responsibilities, and coordination. We found that 
the documents include some, but not all, of the elements of these 
characteristics. With respect to the fourth characteristic, we found that the 
documents include elements relating to agency resources associated with 
the strategy such as descriptions of current activities of NNI member 
 NIOSH has previously published research summaries in its 
nanotechnology research progress reports. NIOSH officials told us that a 
forthcoming progress report will also document the results of performance 
measures identified in their nanotechnology EHS strategy. NSF reports 
planned EHS research activities as part of its annual budget request, but 
does not identify performance targets or measures for its nanotechnology 
EHS research beyond funding requested. According to an NNCO official, 
the NEHI working group is piloting an effort to gather information from the 
NNI member agencies to assess high-level progress toward meeting NNI 
research needs, but has not released the results of this work. 
                                                                                                                       
57CPSC, 2010 Performance and Accountability Report (November 2010); Department of 
Health and Human Services, Food and Drug Administration, FY2012 Online Performance 
Appendix; Department of Health and Human Services, National Institutes of Health, 
FY2012 Online Performance Appendix. 
58EPA, Nanomaterial Research Strategy, EPA 620/K-09/011 (June 2009); NIOSH, 
Strategic Plan for NIOSH Nanotechnology Research and Guidance, Department of Health 
and Human Services (NIOSH) Publication No. 2010-105 (November 2009); NIST, 
Nanomaterial Environmental, Health and Safety (Nano-EHS) Program Plan, FY10-FY14. 
Resources, Investments, and 
Risk Management and 
Organizational Roles, 
Responsibilities, and 
Coordination (Desirable 
Characteristics 4 and 5) 
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agencies and current investment levels. However, we found that the 
documents do not include, or do not fully develop, other elements such as 
the costs and types of resources—for example human capital or research 
and development costs—associated with implementing the strategy. An 
NNCO official told us that the NNI does not analyze the costs of 
resources to meet the EHS research needs because it does not control 
the funding for member agencies, and that each agency allocates funding 
and prioritizes its activities based on its mission area and available 
budget. According to this official, the 2011 NNI EHS research strategy 
identifies research goals, but it is up to the agencies to determine how 
their funding should be spent. Similarly, a NIST official told us that the 
NNI cannot dictate to agencies how or what research to fund. With 
respect to the fifth characteristic pertaining to organizational roles, 
responsibilities, and coordination, we found that the documents include 
elements such as lead, support, and partner roles for agencies and 
processes for coordination and collaboration, but do not include, or do not 
fully develop, other elements such as an accountability and oversight 
framework. The strategy documents include detailed descriptions of the 
NNI structure, describe coordination mechanisms such as the NEHI 
working group, and provide examples of collaborative activities related to 
EHS research. As we reported above, we found that NNI member 
agencies have engaged in numerous collaborative projects with federal 
and nonfederal partners and nonfederal partners generally rated these 
collaborations as generally or very useful. However, the strategy 
documents do not provide details on oversight of agency roles or how 
agencies will be held accountable to the goals and research needs of the 
NNI strategy documents. 
The NNI strategy documents also partially address the sixth characteristic 
describing integration and implementation. This characteristic describes 
how the national strategy documents relate to subordinate levels of 
government and their plans to implement the strategy. As we have 
previously reported, to achieve a common outcome, collaborating 
agencies need to establish strategies that work in concert with those of 
their partners or are joint in nature.59
                                                                                                                       
59GAO, Results-Oriented Government: Practices That Can Help Enhance and Sustain 
Collaboration Among Federal Agencies, 
 We found that the NNI strategy 
documents include limited information regarding the elements of this 
characteristic. For example, the 2011 NNI EHS research strategy 
GAO-06-15 (Washington, D.C.: Oct. 21, 2005). 
Integration and Implementation 
(Desirable Characteristic 6) 
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describes a framework for implementation, but does not provide detailed 
implementation guidance.60
Five of the seven NNI member agencies we reviewed have developed 
such agency-level nanotechnology EHS research strategies. As noted 
above, EPA, NIOSH, and NIST have developed strategic plans 
specifically for EHS research. In addition, FDA has published a strategic 
plan for its regulatory science research efforts, which include 
nanotechnology, and developed a research plan specifically targeting 
nanotechnology.
 In addition, we found that the NNI strategy 
documents generally do not include information on the NNI member 
agencies’ nanotechnology EHS strategies or plans or their integration 
with the national strategy. 
61 Furthermore, NSF officials told us that the agency 
describes its strategic direction for nanotechnology, including current and 
proposed activities and funding by PCA, in its annual budget request.62
                                                                                                                       
60The 2011 NNI EHS research strategy states that, because individual agency priorities 
may differ in scope and focus from the NNI research needs, the NSTC relies on 
coordination through NEHI to ensure integration of agency plans.  
 
CPSC includes nanotechnology as an external risk factor for its 
agencywide strategic plan, but the plan does not address EHS research 
directly. NIH officials told us they do not have agency or institute-specific 
strategic plans that specifically address nanotechnology EHS research, 
but nanotechnology EHS research plans developed by its institutes 
conform to the NNI strategy. Of the five agencies with nanotechnology 
EHS-related strategies, two—FDA and NIOSH—explicitly align agency 
research goals in their strategic plans for nanotechnology to NNI EHS 
research needs. The FDA and NIOSH strategic plans describe the 
agencies’ EHS research goals, their framework for meeting those goals, 
and which NNI EHS research needs will be advanced. NIST’s Nano-EHS 
program plan, EPA’s Nanomaterial Research Strategy, and NSF’s budget 
request to Congress describe agency research objectives. The 
documents do not explicitly identify NNI research needs; however, 
agency officials told us that they reflect the NNI strategic documents. The 
2011 NNI strategic plan reports that NNI member agencies have initiated 
61FDA, Advancing Regulatory Science at FDA (August 2011), 
http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm, 
and FDA, Nanotechnology Regulatory Science Research Plan, 
http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ucm273325.htm.  
62NSF, NSF FY2012 Budget Request to Congress, 
http://www.nsf.gov/about/budget/fy2012/index.jsp. 
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a mapping exercise to evaluate how this strategic plan relates to NNI 
member agencies’ strategic plans and to the priorities of the 
administration. In addition, according to NNI member agency officials, 
individual agencies’ implementation efforts of the 2011 NNI EHS research 
strategy are discussed at NEHI meetings. However, the results of this 
mapping exercise and proceedings of the NEHI are not publically 
available. 
 
The increasing commercialization of nanotechnology-enabled products and 
information gaps related to nanotechnology EHS impacts underscore the 
importance of ensuring progress toward meeting EHS strategic goals and 
research needs. The NNI strategy documents help shape the policies, 
programs, priorities, resource allocations, and standards related to 
nanotechnology EHS research and activities. The NNI strategy documents 
address or partially address the desirable characteristics of effective 
national strategies, including overarching strategic goals and objectives 
such as the EHS research needs. However, the documents do not include 
some elements of the characteristics, which could make it more difficult for 
federal agencies and other stakeholders to implement the strategy and 
achieve the identified results. For example, progress toward achieving the 
strategy documents’ goals and research needs cannot be tracked because 
the NNI does not report specific performance information, such as 
performance measures, targets, or time frames. In addition, the NNI 
strategy documents do not include estimates of the costs and types of 
resources associated with these goals and research needs. 
Developing and coordinating performance information and cost estimates 
for the NNI’s nanotechnology EHS research may be challenging because 
of the varied missions and priorities of the NNI member agencies. 
However, not having performance information that is aligned with the 
strategic goals and research needs of the NNI makes it difficult for 
agencies, policymakers, and stakeholders to determine the collective 
progress of the national nanotechnology program. Furthermore, 
developing performance information and including it in NNI strategy 
documents could help to strengthen two other desirable characteristics 
that the documents partially address. Specifically, this information could 
also support an accountability and oversight framework—that is currently 
not well-developed—by linking agency activities to specific measures of 
performance and creating consistent benchmarks to judge the overall 
progress of the NNI member agencies. In addition, developing this 
information could facilitate better integration between the NNI strategy 
documents and the NNI member agencies’ nanotechnology EHS 
Conclusion 
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research strategies and goals. Providing cost estimates related to the NNI 
EHS research needs would allow the NNI member agencies, 
policymakers, and stakeholders to assess if investments are 
commensurate with costs of the identified needs. The NSTC, which is 
administered by the OSTP, does not direct funding to meet the NNI 
research needs; however, rough estimates of their costs could serve as 
guidance to the NNI member agencies as they individually determine their 
own budgets and priorities. In addition, the NSTC is well-positioned to 
develop these estimates due to its coordinating role across the member 
agencies of the NNI and corresponding access to expertise at these 
agencies. Developing performance information and cost estimates could 
also support the analysis of the progress made toward achieving the 
goals and priorities established for the program, as required by the 21st 
Century Nanotechnology Research and Development Act. 
In addition, we are reiterating our 2008 recommendation that the Director 
of OSTP, in consultation with the Directors of the NNCO and OMB, 
provide better guidance to agencies on how to report their 
nanotechnology EHS research.63
 
 The continued absence of detailed 
guidance on how to report research under PCA 7 has contributed to the 
data reporting problems we identified. Therefore, agencies, policymakers, 
and stakeholders do not have access to accurate, consistent, and 
complete data on the federal government’s investment in nanotechnology 
EHS research. Without reliable and up-to-date data, it will be difficult for 
agencies to accurately assess and report their progress toward their own 
performance measures, as well as the EHS research goals and needs 
identified in the 2011 NNI EHS research strategy. 
To better offer policymakers and implementing agencies a management 
tool that can help ensure accountability and more effective results, we are 
making two recommendations to the Director of OSTP: 
We recommend that the Director of OSTP coordinate development by the 
NNI member agencies of performance measures, targets, and time 
frames for nanotechnology EHS research that align with the research 
needs of the NNI, consistent with the agencies’ respective statutory 
authorities, and include this information in publicly available reports. 
                                                                                                                       
63GAO-08-402. 
Recommendations for 
Executive Action 
 
  
 
 
 
Page 52 GAO-12-427  Nanotechnology 
We also recommend that, to the extent possible, the Director of OSTP 
coordinate the development by the NNI member agencies of estimates of 
the costs and types of resources necessary to meet the EHS research 
needs. 
 
We provided a draft of this report to the Director, OSTP; Secretary, 
Commerce; Chairman, CPSC; Administrator, EPA; Secretary, Health and 
Human Services; and Director, NSF. OSTP and the agencies neither 
agreed nor disagreed with the recommendations. OSTP and Health and 
Human Services provided technical and clarifying comments, which we 
incorporated as appropriate. The Department of Commerce, CPSC, EPA, 
and NSF indicated they had no comments on the report. 
 
As agreed with your office, unless you publicly announce the contents of 
this report earlier, we plan no further distribution until 30 days from the 
report date. At that time, we will send copies to the Director, OSTP; 
Secretary, Commerce; Chairman, CPSC; Administrator, EPA; Secretary, 
Health and Human Services; Director, NSF; and other interested parties. 
The report also will be available at no charge on the GAO website at 
http://www.gao.gov. 
If you or your staff have any questions about this report, please contact 
me at (202) 512-3841 or ruscof@gao.gov. Contact points for our Offices 
of Congressional Relations and Public Affairs may be found on the last 
page of this report. GAO staff who made major contributions to this report 
are listed in appendix III. 
Sincerely yours, 
Frank Rusco 
Director, Natural Resources  
 and Environment 
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Our review examines (1) changes in federal funding for nanotechnology 
environmental, health, and safety (EHS) research from fiscal years 2006 
to 2010; (2) the nanomaterials that National Nanotechnology Initiative 
(NNI) member agencies focused on in their EHS research in fiscal year 
2010; (3) the extent to which NNI member agencies collaborate with 
stakeholders on nanotechnology EHS research and related strategies; 
and (4) the extent to which NNI strategy documents address desirable 
characteristics of national strategies. 
To conduct this work, we reviewed EHS research efforts funded by seven 
NNI member agencies, which collectively funded 93 percent of EHS 
research dollars in fiscal year 2010: the National Science Foundation 
(NSF), National Institutes of Health (NIH), Environmental Protection 
Agency (EPA), National Institute for Occupational Safety and Health 
(NIOSH), Food and Drug Administration (FDA), National Institute of 
Standards and Technology (NIST), and the Consumer Product Safety 
Commission (CPSC). The first six of these agencies represent the top six 
providers of EHS research funding from fiscal year 2006 to fiscal year 
2010, and CPSC has an important role in ensuring the safe use of 
nanotechnology in consumer products. 
To examine recent changes in federal funding for nanotechnology EHS 
research, we reviewed information published by the National Science and 
Technology Council (NSTC) in the NNI Supplements to the President’s 
Budget. Specifically, we reviewed the actual agency investments reported 
in each program component area for fiscal years 2006 through 2010 for 
all NNI member agencies funding nanotechnology research.1
                                                                                                                       
1See NSTC, Committee on Technology, Subcommittee on Nanoscale Science, 
Engineering, and Technology, The National Nanotechnology Initiative Supplement to the 
President’s 2012 Budget (February 2011); The National Nanotechnology Initiative 
Supplement to the President’s 2011 Budget (February 2010); The National 
Nanotechnology Initiative Supplement to the President’s 2010 Budget (May 2009); The 
National Nanotechnology Initiative Supplement to the President’s 2009 Budget 
(September 2008); and The National Nanotechnology Initiative Supplement to the 
President’s 2008 Budget (July 2007). 
 For the 
dollar amounts that we adjusted for inflation, we used the Biomedical 
Research and Development Price Index to report funding in constant 
2010 dollars. We consulted with the Office of Management and Budget 
(OMB) and officials at the seven selected agencies to determine the type 
of budget information reported as actual agency investments in these 
documents. For fiscal year 2010, the most recent year for which actual 
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agency investment data were available, we also collected quantitative 
and qualitative project-level data (such as project funding amounts and 
project abstracts or progress reports) on all research projects that the 
seven selected agencies had categorized as Program Component Area 
(PCA) 7 (EHS research). The agencies do not report project-level data to 
OMB annually but report their total EHS research funding to OMB 
annually for inclusion in the NNI budget supplements published by NSTC. 
Therefore, we reviewed data on the individual projects included in the 
agencies’ total EHS research funding in 2010. We provided the agencies 
with a spreadsheet template to use in listing their projects, which we 
based on the spreadsheet OMB had used in its data calls to collect 
project-level data from agencies on their 2006 and 2009 EHS research 
projects. Consistent with the approach used in OMB’s data calls, we did 
not ask the agencies to use a standardized definition of what constitutes a 
“project;” instead, we deferred to each agency to identify their projects 
and consulted with agency officials as needed. 
For some projects at NIH, NIOSH, and NIST, we grouped together some 
of the agencies’ data entries and counted them together for the purposes 
of our analyses. Consequently, the numbers of projects we are reporting 
may not match the number reported by these agencies elsewhere. 
Specifically, for NIH, we grouped the 14 supplement grants together with 
their main grants and counted each of those groups as a single project. 
We also grouped together the individual subprojects of each of NIH’s 
multiproject “parent” grants reported as EHS and counted each of those 
groups as a single project, for a total of seven groups of multiproject 
grants. In addition, we grouped together two grants made by different NIH 
institutes for the same project. For NIOSH, we identified two project 
entries with identical project descriptions. After consulting with NIOSH 
officials, we grouped those two entries together and counted them as a 
single project. For NIST, the agency reported a separate entry for each of 
its Project Tracking Numbers and explained that a single technical project 
is often associated with more than one Project Tracking Number. NIST 
officials instructed us to group together the entries with identical titles and 
count each of those groups as a single project. 
To assess the reliability of the agencies’ fiscal year 2010 data, we sent 
each of the seven selected agencies a set of questions regarding the data 
and the information systems used to produce and store them. We also 
reviewed related supporting documentation, such as user manuals and 
data dictionaries for information systems, and, for some projects, copies 
of the associated interagency agreements. We examined the data for 
obvious errors, compared each agency’s total fiscal year 2010 PCA 7 
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funding reported to us to the totals reported in the NNI Supplement to the 
President’s 2012 Budget, and consulted with agency officials to 
understand the reasons for any differences. We determined that the data 
were sufficiently reliable for the purposes of our analyses. However, we 
did not attempt to verify the funding amounts reported for each project—
for example, by reviewing documentation of agencies’ actual 
expenditures for each project. 
We reviewed the qualitative project data, including abstracts and project 
reports, to assess whether the agencies had appropriately categorized 
the research projects they reported as EHS research—that is, whether 
the projects met the definition of program component area (PCA) 7. As 
described in this report, the definition of PCA 7—research primarily 
directed at understanding the EHS impacts of nanotechnology 
development and corresponding risk assessment, risk management, and 
methods for risk mitigation—is the only written guidance available to 
agencies on how to report their nanotechnology research in this program 
component area. Determining whether research meets this definition is an 
inherently subjective process. Therefore, rather than definitively conclude 
that any projects did not meet the definition, we assigned projects a 
designation of “not clearly PCA 7” if we were ultimately unable to identify 
any EHS research, or it was not clear that EHS was the primary focus of 
the research. For example, some projects studied various 
nanotechnology-enabled drugs, but it was not clear to what extent the 
research was directed at the safety of the drugs versus their efficacy. 
Some other projects appeared to be closely related to program 
component areas other than PCA 7, such as PCA 4 (instrumentation 
research, metrology, and standards for nanotechnology) or PCA 8 
(education and societal dimensions), and it was not clear that PCA 7 was 
the most appropriate category. To minimize bias and to ensure the 
consistency of our evaluation, two analysts independently analyzed the 
project data and used their professional judgment to assess whether each 
project met the PCA 7 definition. The two analysts discussed those 
projects where they did not agree on whether the research was primarily 
directed at EHS and reached agreement. For categorization of projects 
that appeared questionable to us, we generally asked agencies to explain 
why they had reported those projects as EHS research. We reviewed 
agencies’ responses and modified our determinations for projects as 
appropriate given the additional support provided by the agencies. For 
two projects funded by NIST and 18 by NSF, the agencies had reported 
only a portion of the total project funding under PCA 7. In those instances, 
we assessed whether at least some of the project was primarily directed 
at EHS. However, we did not verify that the funding amounts reported as 
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EHS research were correct because that information is, according to 
these agencies’ officials, based on the discretion of the knowledgeable 
agency program staff. We also reviewed our 2008 report in this area, 
which found that 22 of 119 fiscal year 2006 projects reported as EHS 
research were miscategorized, and recommended that the Director of the 
Office of Science and Technology Policy (OSTP), in consultation with the 
Directors of the National Nanotechnology Coordinating Office and OMB, 
provide better guidance to agencies on how to report nanotechnology 
EHS research.2
To identify the nanomaterials that the seven selected NNI member 
agencies focused on in their EHS research in fiscal year 2010, we 
reviewed qualitative project data—such as abstracts and progress 
reports—for those projects we determined were primarily directed at EHS. 
We also consulted with agency officials. One analyst identified, and a 
second analyst verified, the nanomaterials in the project documentation. 
We attempted to identify the nanomaterials that the projects actually 
studied in fiscal year 2010. However, some projects are multiyear efforts. 
The level of detail in the documentation we reviewed for each project 
varied, and the documentation did not always indicate which materials 
were studied in which years. For the purposes of our analysis, we 
assumed that all nanomaterials identified for a project were studied in 
2010, unless the documentation specified otherwise. It is possible that 
some additional nanomaterials were studied by these projects but not 
referenced in the documents we reviewed. It is also possible that some of 
the nanomaterials referenced in project documents were not actually 
studied until later years of a project. However, we do not have any 
reasons to suspect that such variances would be significant or would 
substantially change our findings. 
 We asked OMB and OSTP to identify any guidance 
provided to agencies on how to report their EHS research and to describe 
any steps taken since our prior report to improve such guidance. 
We assigned each particular nanomaterial identified to one of five 
categories: carbon-based nanomaterials; metal-based nanomaterials; 
semiconductor-based nanomaterials; organic nanomaterials; and other 
nanomaterials. In addition, some projects were not targeted to particular 
nanomaterials. An analyst with previous academic and professional 
                                                                                                                       
2GAO, Nanotechnology: Better Guidance Is Needed to Ensure Accurate Reporting of 
Federal Research Focused on Environmental, Health, and Safety Risks, GAO-08-402 
(Washington, D.C.: Mar. 31, 2008). 
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experience in nanotechnology helped identify the categories we used and 
verified that the materials were placed in the appropriate categories for 
each project. After reviewing the fiscal year 2010 EHS research by the 
selected agencies, we selected the five categories of nanomaterials we 
used, based on the primary composition of the materials, to encompass 
the range of materials identified in the projects. To inform our selection of 
the categories we used for grouping nanomaterials, we reviewed 
literature related to nanotechnology EHS issues from federal agencies 
(NIH and EPA), nonprofit organizations (the Woodrow Wilson 
International Center for Scholars’ Project on Emerging Nanotechnologies 
and the World Technology Evaluation Center, Inc.), and a market 
research firm that tracks nanotechnology (Lux Research). We found that 
various classes or categories were used to present information on 
nanomaterials. For materials identified as composites, we assigned them 
to categories based on the primary nanomaterials from which they were 
formed—for example, we assigned carbon nanotube nanocomposites to 
the carbon-based nanomaterials category. 
To determine the extent to which the NNI member agencies collaborate 
with stakeholders on nanotechnology EHS research and related 
strategies, we (1) discussed with agency officials how their agencies 
collaborate on nanotechnology EHS research and NNI’s role in facilitating 
that collaboration, and (2) we obtained documentation on these 
collaborative efforts. We conducted a review of formal collaborative 
efforts (i.e., those that are documented in written agreements) that 
focused on nanotechnology EHS research initiated from February 2008 to 
October 2011 while the 2008 NNI Strategy for Nanotechnology-Related 
EHS Research was in effect.3
                                                                                                                       
3NSTC, Committee on Technology, Subcommittee on Nanoscale Science, Engineering, 
and Technology, National Nanotechnology Initiative Strategy for Nanotechnology-Related 
Environmental, Health, and Safety Research (February 2008). 
 We chose this time frame because this 
strategy—the first NNI strategy to focus on EHS research—established 
collaboration as necessary for its implementation efforts. The strategy 
was in effect for a number of years, which allowed us to get a more 
complete picture of the number of collaborative projects completed during 
its implementation. We only included collaborative efforts that were 
formalized by written agreements because those provided a clearer 
description of the agencies’ contributions of resources. We obtained an 
initial list of such efforts from published NNI sources as well as an OMB 
data call used to compile EHS-related nanotechnology projects for the 
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2011 NNI EHS research strategy. We sent our initial list to the selected 
NNI agencies for their review and revision, and analyzed supporting 
documents provided by the agencies. We provide relevant information 
from the supporting documents for each of the projects within our scope 
in appendix II. 
We administered a web-based questionnaire to a nonprobability sample 
of nonfederal stakeholders,4 including those affiliated with academia, 
companies, nongovernmental organizations (NGO), and state and local 
governments, to obtain their views on collaboration with the NNI member 
agencies on EHS research and the EHS research strategies. Because 
the population of nonfederal stakeholders is diverse, wide-ranging, and 
difficult to reliably define, we chose to use a nonprobability sample of 
individuals who (1) had expertise in the field of nanotechnology, and (2) 
had interacted with the NNI in the past few years, or who were 
representatives of organizations and companies suggested to us through 
our scoping interviews. We identified relevant potential respondents from 
several sources, including the list of participants in NNI workshops that 
were used to solicit input for the 2011 NNI EHS research strategy5
                                                                                                                       
4A nonprobability sample is a sample in which some items in the population have no 
chance, or an unknown chance, of being selected. Results from nonprobability samples 
cannot be used to make inferences about a population. However, information from the 
sample provided illustrative examples. 
 and 
participants in a review of the NNI by the President’s Council of Advisors 
on Science and Technology. We also included members of 
nanotechnology-related trade associations and other organizations 
through interviews with nanotechnology experts using an iterative 
process, often referred to as “snowball sampling.” We excluded federal 
employees and contractors, individuals or organizations that are not 
located in the United States, and those for whom we could not obtain 
contact information. In addition, individuals who were not considered to 
have expertise in the nanotechnology field based on their job titles were 
5In 2009 and 2010, the NNI held four public workshops: (1) Human and Environmental 
Exposure Assessment (February 2009); (2) Nanomaterials and the Environment & 
Instrumentation, Metrology, and Analytical Methods (October 2009); (3) Nanomaterials 
and Human Health & Instrumentation, Metrology, and Analytical Methods (November 
2009); and (4) Risk Management Methods & Ethical, Legal, and Societal Implications of 
Nanotechnology (March 2010).  
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excluded.6
The questions included in the questionnaire were developed using issues 
raised in our scoping interviews and background literature search. Most of 
our questions provided respondents with answer options identified 
through our interviews and background literature searches. In certain 
cases, we also provided respondents with an “other” category which 
allowed them to write in additional responses we did not identify. 
However, because few respondents chose this option, we presented only 
some of these responses as illustrative examples. The questionnaire 
went through internal reviews, including independent GAO survey 
experts, as well as four pretests with two stakeholders who work for 
companies, one academic, and one stakeholder from an NGO. We chose 
the pretesters to reflect the diversity of affiliations of the nanotechnology 
experts included among our respondents. We revised and clarified the 
questions and introductory material to the questionnaire based on 
comments obtained in the internal reviews and from the pretesters. 
 These sources provided us with a list of 228 stakeholders 
chosen as potential respondents. Of these 228 individuals, five 
subsequently were excluded from our sample because they had invalid e-
mail addresses, were duplicates, or were not available for an extended 
period, giving us a final sample of 223 potential respondents. We 
categorized the population surveyed by affiliation type, usually based on 
information provided on each entity’s website, as follows: (1) “academic,” 
which includes universities or university-affiliated programs or centers; (2) 
“company,” which includes companies, corporations, or other for-profit 
entities whose primary purpose is to sell products, services, or 
information; (3) “organization,” which includes NGOs or other entities 
whose primary purpose is public interest or mutual benefit; and (4) “state 
and local government.” 
We administered the questionnaire through a secure server. When we 
completed the final survey questions and format, we sent an e-mail 
announcement of the questionnaire to the nonfederal stakeholders in our 
sample on September 23, 2011. Stakeholders were notified that the 
questionnaire was available online and were given unique passwords and 
user names on October 11, 2011. We sent follow-up e-mail messages on 
                                                                                                                       
6For example, administrative assistants or staff managers were excluded because they 
are unlikely to have subject matter expertise. In another case, an individual in a 
consultancy that does not focus on nanotechnology was excluded, based on advice from 
the head of a nanotechnology trade association. 
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October 18, 2011, October 25, 2011, and November 2, 2011 to those who 
had not yet responded. Then we contacted all nonrespondents by 
telephone, starting on October 21, 2011. The questionnaire was available 
online until December 6, 2011. 
Because this was not a sample survey, it has no sampling errors. 
However, the practical difficulties of conducting any survey may introduce 
errors, commonly referred to as nonsampling errors. For example, 
difficulties in interpreting a particular question, sources of information 
available to respondents, or entering data into a database or analyzing 
them can introduce unwanted variability into the survey results. We took 
steps in developing the questionnaire, collecting the data, and analyzing 
them to minimize such nonsampling errors. For example, we worked with 
social science survey specialists to design the questionnaire. We 
pretested the draft questionnaire with four nonfederal stakeholders to 
ensure that the questions were relevant, clearly stated, and easy to 
understand. When we analyzed the data, an independent analyst 
checked all computer programs. Since this was a web-based 
questionnaire, respondents entered their answers directly into the 
electronic questionnaire, eliminating the need to key data into a database, 
minimizing error. 
Of the 223 potential respondents, 138 completed the questionnaire during 
our time frame, for an overall response rate of about 62 percent.7
To determine the extent the NNI strategy documents address desirable 
characteristics of national strategies, we compared three key NNI 
strategic documents
 The 
numbers responding by affiliation type as categorized by us were  
(1) “academic”—42 out of 62; (2) “company”—65 out of 114;  
(3) “organization”—24 out of 39; and (4) “state and local government”— 
7 out of 8. 
8
                                                                                                                       
7Not all individuals responded to every question. 
 against criteria for desirable characteristics of 
8These three strategic documents are: (1) NSTC, Committee on Technology, 
Subcommittee on Nanoscale Science, Engineering, and Technology, National 
Nanotechnology Initiative Strategic Plan (February 2011); (2) NSTC, Committee on 
Technology, Subcommittee on Nanoscale Science, Engineering, and Technology, 
National Nanotechnology Initiative Environmental, Health, and Safety Research Strategy 
(October 2011); and (3) NSTC, Committee on Technology, Subcommittee on Nanoscale 
Science, Engineering, and Technology, The National Nanotechnology Initiative 
Supplement to the President’s 2012 Budget (February 2011). 
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national strategies. Prior GAO reports have identified six desirable 
characteristics for national strategy documents that would help shape the 
policies, programs, priorities, resource allocations, and standards that 
would enable federal agencies and other stakeholders to implement the 
strategies and achieve the identified results.9 National strategies that 
address these characteristics offer policymakers and implementing 
agencies a management tool that can help ensure accountability and 
more effective results.10
Table 5: Elements of Desirable Characteristics of National Strategies 
 Table 5 provides the desirable characteristics 
and the elements we looked for. 
Desirable characteristic  Brief description  Elements of characteristic 
Purpose, scope, and 
methodology 
Addresses why the strategy was 
produced, the scope of its coverage, 
and the process by which it was 
developed. 
• Statement of broad or narrow purpose, as 
appropriate. 
• How it compares and contrasts with other national 
strategies. 
• What major functions, mission areas, or activities it 
covers. 
• Principles or theories that guided its development. 
• Impetus for strategy (e.g., statutory requirement or 
event). 
• Process to produce strategy (e.g., interagency task 
force; state, local, or private input). 
• Definition of key terms. 
Problem definition and risk 
assessment 
Addresses the particular national 
problems and threats the strategy is 
directed toward. 
• Discussion or definition of problems, their causes, 
and operating environment. 
• Risk assessment, including an analysis of threats and 
vulnerabilities. 
• Quality of data available (e.g., constraints, 
deficiencies, and “unknowns”). 
                                                                                                                       
9GAO, National Capital Region: 2010 Strategic Plan is Generally Consistent with 
Characteristics of Effective Strategies, GAO-12-276T (Washington, D.C.: Dec. 7, 2011); 
Influenza Pandemic: Further Efforts Are Needed to Ensure Clearer Federal Leadership 
Roles and an Effective National Strategy, GAO-07-781 (Washington, D.C.: Aug. 14, 
2007); Financial Literacy and Education Commission: Further Progress Needed to Ensure 
an Effective National Strategy, GAO-07-100 (Washington, D.C.: Dec. 4, 2006); Combating 
Terrorism: Evaluation of Selected Characteristics in National Strategies Related to 
Terrorism, GAO-04-408T (Washington, D.C.: Feb. 3, 2004). 
10GAO-07-781. 
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Desirable characteristic  Brief description  Elements of characteristic 
Goals, subordinate objectives, 
activities, and performance 
measures 
Addresses what the strategy is trying 
to achieve, steps to achieve those 
results, as well as the priorities, 
milestones, and performance 
measures to gauge results. 
• Overall results desired (i.e., “end-state”). 
• Hierarchy of strategic goals and subordinate 
objectives. 
• Specific activities to achieve results. 
• Priorities, milestones, and outcome-related 
performance measures. 
• Specific performance measures. 
• Process for monitoring and reporting on progress. 
• Limitations on progress indicators. 
Resources, investments, and 
risk management 
Addresses what the strategy will cost, 
the sources and types of resources 
and investments needed, and where 
resources and investments should be 
targeted by balancing risk reductions 
and costs. 
• Resources and investments associated with the 
strategy. 
• Types of resources required, such as budgetary, 
human capital, information technology, research and 
development, contracts. 
• Sources of resources (e.g., federal, state, local, and 
private). 
• Economic principles, such as balancing benefits and 
costs. 
• Resource allocation mechanisms, such as grants, in-
kind services, loans, or user fees. 
• “Tools of government” (e.g., mandates or incentives 
to spur action). 
• Importance of fiscal discipline. 
• Linkage to other resource documents (e.g., federal 
budget). 
• Risk management principles. 
Organizational roles, 
responsibilities, and coordination 
Addresses who will be implementing 
the strategy, what their roles will be 
compared to others, and mechanisms 
for them to coordinate their efforts. 
• Roles and responsibilities of specific federal 
agencies, departments, or offices. 
• Roles and responsibilities of state, local, private, and 
international sectors. 
• Lead, support, and partner roles and responsibilities. 
• Accountability and oversight framework. 
• Potential changes to current organizational structure. 
• Specific processes for coordination and collaboration. 
• How conflicts will be resolved. 
Integration and implementation  Addresses how a national strategy 
relates to other strategies’ goals, 
objectives, and activities—and to 
subordinate levels of government and 
their plans to implement the strategy. 
• Integration with other national strategies (horizontal). 
• Integration with relevant documents from 
implementing organizations (vertical). 
• Details on specific federal, state, local, or private 
strategies and plans. 
• Implementation guidance. 
• Details on subordinate strategies and plans for 
implementation (e.g., human capital, and enterprise 
architecture). 
Source: GAO-04-408T. 
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To assess whether the documents addressed these desirable 
characteristics, two analysts independently reviewed the three NNI 
strategy documents for the elements of each characteristic. We examined 
the documents for inclusion of each element and for sufficient specificity 
and detail. The two analysts compared their assessments, discussed any 
discrepancies, and agreed upon a determination for each element. Each 
characteristic was then given a rating of “address,” “partially address,” or 
“does not address.” According to our methodology, the strategy 
documents “address” a characteristic when it explicitly includes all, or 
nearly all, elements of the characteristic and has sufficient specificity and 
detail. The documents “partially address” a characteristic when it includes 
some or most of the elements with sufficient specificity and detail. The 
“partially address” category includes a range that varies from explicitly 
including most of the elements to including as few as one of the elements 
of a characteristic. A strategy “does not address” a characteristic when it 
does not include any elements of a characteristic or references are too 
vague or general to be useful. 
Because the three NNI documents have different purposes and 
audiences, an individual document need not address each element of 
each desirable national strategy characteristic. Therefore, we reviewed 
the three NNI strategy documents as a whole. In the case of the 2011 
NNI strategic plan and Supplement to the President’s 2012 Budget, we 
focused on sections related to EHS research, where applicable. 
We identified agency documents related to nanotechnology EHS 
research strategies and performance. Documents were identified based 
on interviews with agency officials, review of agency websites, and a data 
collection instrument sent to agencies requesting any documentation 
related to the planning or performance of their nanotechnology EHS 
research programs. In order to assess the extent of linkage between 
agencies’ nanotechnology EHS research and national priorities of the 
NNI, we evaluated agency management documents for explicit referrals 
to NNI activities or guidance, including strategic documents such as the 
NNI strategic plan or EHS research strategy, or activities of the NNI’s 
planning and coordinating bodies. We also reviewed agencies’ 
Performance Reports in order to assess agencies' use of performance 
information related to nanotechnology EHS research efforts. 
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We conducted this performance audit from February 2011 through May 
2012 in accordance with generally accepted government auditing 
standards. Those standards require that we plan and perform the audit to 
obtain sufficient, appropriate evidence to provide a reasonable basis for our 
findings and conclusions based on our audit objectives. We believe that the 
evidence obtained provides a reasonable basis for our findings and 
conclusions based on our audit objectives. 
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Table 6 identifies collaborative nanotechnology EHS research project 
agreements initiated by the NNI member agencies included in our review 
from February 2008 to October 2011. The table identifies only those 
projects specifically focused on nanotechnology. All the information in the 
table is based on the written agreements, which were provided by NNI 
member agencies’ officials. 
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Table 6: Collaborative Nanotechnology Environmental, Health, and Safety Research Agreements 
Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
Consumer Product Safety 
Commission (CPSC), 
National Institute of 
Standards and Technology 
(NIST) 
NA April 2008 Memorandum of 
understanding 
Memorandum of 
understanding between 
CPSC and NIST’s Building 
and Fire Research 
Laboratory 
Develop best practices to identify the presence of and 
characterize and quantify potential release of 
nanomaterials from flame retardant consumer products, 
to help assess the safety of these products. The 
cooperating agencies plan to work closely to expedite 
the development and availability of methods for the 
characterization and quantification of the release of 
nanomaterials from a variety of products (e.g., textiles, 
plastics) which are assessed using any of a number of 
standard fire tests. 
CPSC, National Institute 
for Occupational Safety 
and Health (NIOSH) 
NA July 2008 Interagency 
agreement 
Nano product exposure 
assessment 
Conduct laboratory investigations on the emissions of 
nanoscale titanium dioxide from selected consumer 
products. The project also is to involve developing the 
appropriate sampling and analysis methods for 
nanomaterials incorporated into selected consumer 
products. The first products to be investigated are 
bathroom cleaners that utilize titanium dioxide as a 
catalyst to destroy bacteria or to break down organic 
material. These products are believed to be used by 
consumers and in occupational settings (e.g., hotel 
cleaning). CPSC staff interests involve emissions during 
consumer use while NIOSH is concerned with emissions 
that occur in occupational use scenarios. 
CPSC, NIST NA Initiated July 
2009, extended 
September 2009 
Interagency 
agreement 
Exposure and fire hazard 
assessment of 
nanoparticles in fire safe 
consumer products 
Determine if nanoparticles that are traditionally used to 
improve the fire performance of foam and barrier fabrics 
are released during simulated normal conditions (i.e., 
mechanical compression and saliva). In addition, 
determine if the release of nanoparticles also creates a 
decrease in the fire performance of these components. 
CPSC, NIOSH NA March 2010 Interagency 
agreement 
Pulmonary effects of 
titanium dioxide 
nanoparticles released from 
aerosol spray products 
Evaluate the acute bioactivity of a particulate aerosol 
from a bathroom cleaner or sanitizer containing titanium 
dioxide nanoparticles by exposing rats by inhalation to 
the aerosolized spray particles (low and high dose) for 2 
hours and monitor pulmonary responses at 1, 7, and 28 
days post-exposure. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
CPSC, NIOSH NA April 2010 Interagency 
agreement 
Exposure assessment of 
silver nanoparticles in 
treated products 
Use scientifically credible protocols to evaluate 
exposure potential to nanosilver from related products. 
NIOSH plans to test the broad hypothesis that 
nanosilver is released from products under conditions of 
intended use. 
CPSC, EPA NA May 2010 Interagency 
agreement 
Exposure assessment of 
silver nanoparticles in select 
children’s consumer 
products 
Evaluate children’s potential exposures to nanosilver 
from consumer products marketed exclusively for 
children (e.g., pacifiers, plush toys) using scientifically 
credible protocols. EPA plans to test the broad 
hypothesis that nanosilver is released from children’s 
consumer products under conditions of intended use. 
CPSC, NIOSH NA March 2011 Interagency 
agreement 
Simulated worker exposure 
to silver from use of nano-
enabled consumer products 
Use scientifically defensible methods to evaluate the 
release of silver from consumer products and model 
exposure potential. NIOSH plans to test the broad 
hypothesis that silver is released from nanosilver 
enabled products under conditions of intended use in 
the work environment. 
CPSC, NIOSH NA May 2011 Interagency 
agreement 
Exposure assessment and 
pulmonary effects of silver 
nanoparticles released from 
aerosol spray products 
Characterize the generated particulate from a product 
containing silver nanoparticles aerosol including the 
mass, particle size distribution, and chemical 
composition of the particles. NIOSH staff plan to expose 
rats by inhalation to the aerosolized spray particles (low 
and high dose) for 2 hours and monitor pulmonary 
responses at 1, 7, and 28 days post-exposure. 
CPSC, NIST NA May 2011 Interagency 
agreement 
Exposure assessment of 
carbon nanotubes in sports 
equipment 
Determine if nanomaterials that are reported to be used 
in selected sports equipment are present in these 
products and are released during simulated use 
conditions. In addition, this project seeks to determine if 
the release of nanoparticles improve the performance of 
these products. 
CPSC, NIST NA July 2011 Interagency 
agreement 
Quantify and characterize 
released nanoparticles from 
thermoset and thermoplastic 
samples 
Measure the impact of nanotechnologies on the 
flammability of the thermoplastic- and thermoset-based 
consumer products and develop risk models for human 
exposure to materials released from these consumer 
products. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
CPSC, NIST NA August 2011 Interagency 
agreement 
Characterization of airborne 
nanoparticles released from 
consumer products 
Develop testing and measurement protocols for 
determining the quantities and properties of 
nanoparticles released from flooring finishes and interior 
paints, and their subsequent airborne concentrations. 
Develop essential methods and data to assess the 
release as well as accumulation of nanoparticles at the 
surfaces of these products that seek to assist in 
estimating occupant exposure and developing strategies 
to manage and mitigate these exposures.  
CPSC, Environmental 
Protection Agency (EPA)a 
NA September 2011 Interagency 
agreement 
Risk assessment for 
manufactured nanoparticles 
used in consumer products 
Determine whether the nanoparticles exposures to 
humans and organisms resulting from consumer 
product and environmental exposures will substantially 
differ in both physicochemical and toxicological 
properties from nanoparticles that are newly 
synthesized in the laboratory or incorporated directly 
into a product. These differences may have significant 
consequences with respect to nanoparticles 
bioavailability and other toxicity measures. This study 
plans to test these measures in in vitro and in vivo 
experiments, and produce mechanism-based results 
relating toxic effects to nanoparticles physicochemical 
properties. 
CPSC, National Science 
Foundation (NSF) 
NA September 2011 Interagency 
agreement 
Interagency agreement 
between the CPSC and 
NSF 
Develop innovative tools for measuring the potential 
health impact of nanotechnologies used in the 
flammability treatment of thermoplastic- and thermoset-
based consumer products and develop risk models for 
human exposure to materials released from these 
consumer products. 
EPA United Kingdom 
(UK) Natural 
Environment 
Research Council, 
UK Engineering and 
Physical Sciences 
Research Council, 
UK Department of 
Environment, Food, 
and Rural Affairs, UK 
Environment Agency 
March 2009 Memorandum of 
understanding 
Memorandum of 
understanding for a joint 
request for applications for 
nanotechnology research 
proposals 
Establish a cooperative framework for the EPA, the UK 
Natural Environment Research Council, the UK 
Engineering and Physical Sciences Research Council, 
the UK Department of Environment, Food, and Rural 
Affairs, and the UK Environment Agency to organize, 
plan, and execute a joint Request for Applications for 
research related to the environmental and health 
implications of released nanomaterials. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
EPA, NSF, U.S. 
Department of 
Agriculture’s National 
Institute of Food and 
Agriculture 
NA Solicitation 
issued November 
2009 
Grant or cooperative 
agreement 
Increasing scientific data on 
the fate, transport, and 
behavior of engineered 
nanomaterials in selected 
environmental and 
biological matrices 
Increase scientific knowledge on the partitioning of 
nanomaterials in various media and increase data on 
movement and transformation capacities. Address the 
urgent needs to scientifically understand the fate and 
properties of nanoscale materials and additives that 
may be used or introduced into foods. Assess the 
adequacy of the existing characterization methods to 
study the critical questions, and establish the baseline 
for the needs of new characterization methodology. 
Provide guidance on the extent of future investigation 
needs on the nanoscale food materials and additives. 
EPA, NIST NA July 2011 Interagency 
agreement 
Measurements to support 
research in nanoparticles 
Investigate aggregation of engineered nanoparticles in 
an artifact of air sampling on filter media and investigate 
how engineered nanoparticles change microscopically 
with age in the atmosphere. 
EPA International Life 
Sciences Institute 
Research 
Foundationb 
September 2011 Contract Support for better 
understanding the release 
of nanomaterials to the 
environment workshop 
(Phase 2) 
Evaluate the “state of the science” for release 
measurement for multi-walled carbon nanotubes in 
polymer. The project seeks to use information (methods, 
studies, guidance, etc.) collected in response to a data 
call and literature search and provide that information to 
groups of subject matter experts selected by the 
steering committee. This information is to also be made 
available in the project’s information catalogue to the 
extent it does not reveal confidential business 
information. 
Food and Drug 
Administration (FDA), 
National Institutes of 
Health’s (NIH) National 
Cancer Institute (NCI), and 
NIST  
NA July 2009 Memorandum of 
understanding 
Memorandum of 
understanding between the 
FDA, NCI, and NIST for the 
Nanotechnology 
Characterization Laboratory 
(NCL) and related 
nanotechnology activities 
Facilitate the development of nanotechnologies that 
constitute novel research tools and safer, more effective 
cancer therapies by establishing a framework for 
effective risk identification, assessment, and evaluation 
of emerging products based on nanotechnology. This 
collaboration is to be focused primarily on the NCL and 
directly related activities. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
FDA’s Center for Biologics 
Evaluation and Research, 
NCL, NIST 
Science Applications 
International 
Corporation (SAIC)-
Fredrickc 
February 2011 Grant mechanism or 
other opportunities 
In vitro evaluation of effects 
of engineered 
nanomaterials on blood 
platelets 
Develop a panel of in vitro assays for evaluation of 
effects of nanomaterials on blood platelets. Research 
validation of the assays for different representative types 
of nanomaterials, soluble nanoparticles, and 
nanoobjects in suspension—representative metal, 
carbon, polymer, dendrimer, liposome nanoparticles, 
nanoparticles containing composites, or nanostructured 
macrosurfaces. Investigate a structure-function 
relationship of a nanoparticle-platelet interaction in a 
model of different size-charge modified 
poly(amidoamine) dendrimers. 
FDA’s National Center for 
Toxicological Research, 
Center for Food Safety and 
Applied Nutrition, Center 
for Veterinary Medicine; 
National Toxicology 
Program; Pacific 
Northwest National 
Laboratories 
NA February 2011 Grant mechanism or 
other opportunities 
Development and 
evaluation of exposure 
dosimetry methods to 
optimize the standard in 
vitro mammalian 
genotoxicity assays for 
assessing engineered 
nanomaterials 
Evaluate whether the existing in vitro mammalian 
genotoxicity assay is suitable for assessing the 
genotoxicity of nanomaterials. Explore the possible 
mechanisms underlying genotoxicity of engineered 
nanomaterials by conducting genomic analysis. Identify 
potential improvements to the assay and general 
strategies for evaluating nanomaterials. Examine 
whether the suitable methods and other experiences 
learned from the micronucleus assay are applicable to 
other genotoxicity tests, such as mouse lymphoma 
assay and in vivo micronucleus assay. 
FDA, NCI, NCL SAIC-Fredrickc July, 2011 Interagency 
agreement 
In vitro dermal penetration 
and in vivo distribution of 
nanoparticles used in food 
and cosmetics 
Utilize free and surface model nanoparticles (such as 
dendrimers, nano-silver or nano-gold) with the size 
range typically found in food and cosmetics to assess 
their characteristics and correlate the effect of surface 
modification on the ability of nanomaterials to penetrate 
various tissue barriers in different in vitro and in vivo 
systems. Supply information related to how 
nanomaterial physiochemical properties affect the ability 
of these nanoscale materials to interact with various 
biological systems and, as a result, to evaluate the 
benefits versus the risks when making regulatory 
approval decisions in order to facilitate the development 
and commercialization of safe nano-based cosmetics, 
foods, and other FDA-regulated products. 
FDA’s Center for Food 
Safety and Applied 
Nutrition and National 
Center for Toxicological 
Research 
Key Laboratory for 
Biomedical Effects of 
Nanomaterials and 
Nanosafety, Chinese 
Academy of 
Sciences 
Fiscal year 2011 Grant mechanism or 
other opportunities 
Use of electron spin 
resonance spectroscopy and 
biomarkers of oxidative 
damage to assess the safety 
of nanoscale materials used 
in cosmetics 
Develop rapid and predictive tests to assess toxicity 
elicited by nanosized materials. The tests may be used 
by the agency and the regulated industry to identify 
potentially hazardous nanosized materials in cosmetic 
products. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIH’s National Institute of 
Environmental Health 
Sciences (NIEHS), NIOSH 
NA Initiated in June 
2008 and 
extended in June 
2009 and March 
2010 
Interagency 
agreement 
Comprehensive 
toxicological assessment of 
occupationally-relevant 
exposures 
Characterize workplace exposure to selected 
engineered nanoparticles. This proposal is to focus on 
addressing the lack of exposure data. Twelve field 
investigations at sites where engineered nanoparticles 
are handled and manufactured are to be conducted. 
The focus of these investigations is to be nanoparticles 
of interest to NIEHS and NIOSH. 
NIEHS, NIOSH NA Initiated in 
February 2009 
and extended in 
December 2009 
Interagency 
agreement 
Cardiovascular toxicity 
assessment of subchronic 
inhalation exposure to 
fullerene C60 
Evaluate potential cardiovascular toxicity of subchronic 
inhalation exposure to fullerene C60 in animal models 
using molecular and biochemical analysis of 
cardiovascular tissue and blood samples. The findings 
are to be correlated with the histopathological, particle 
distribution, and blood chemistry results being obtained 
in other National Toxicology Program studies of this 
proposal. 
NCI, NIH’s National 
Institute of Biomedical 
Imaging and 
Bioengineering, NIEHS 
NA Initiated in April 
2010 with 
NIEHS; NCI 
joined in 
September 2010 
Direct citation 
agreement 
Nano registry Establish an authoritative nanomaterial registry, whose 
primary function is to provide consistent and 
authoritative information on the biological and 
environmental interactions of well-characterized 
nanomaterials, as well as links to associated 
publications, modeling tools, computational results and 
manufacturing guidance. The registry seeks to provide a 
curated data source and assessment information on the 
health and environmental effects of well-characterized 
nanomaterials. A set of minimal information about 
nanomaterials, ontology, and standards are to be 
developed through a community effort with broad 
representation to establish the authoritativeness of the 
registry.  
NCI, NCL, NIEHS SAIC-Fredrickc April 2010 Direct citation 
agreement 
NIEHS nanomaterial 
characterization and 
informatics 
NIEHS requests NCI and SAIC-Fredrick support for 
physiochemical characterization of engineered 
nanomaterials. NCL seeks to provide data to support 
and compare in-house characterization from program 
grantees. Facilitate the dissemination of findings and 
provide maximum impact to the field by providing direct 
access to a database for inclusion of nanomaterials 
physiochemical characterization and biological response 
data. 
      
      
 
Appendix II: Collaborative 
Nanotechnology Environmental, Health, 
and Safety Research Agreements 
 
 
Page 72 GAO-12-427  Nanotechnology 
Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIEHS, NIOSH NA November 2010 Interagency 
agreement 
Comprehensive 
toxicological assessment of 
occupationally-relevant 
exposures 
Identify and assess workplaces where select 
engineered nanomaterials are manufactured or used 
and characterize potential worker exposures to those 
nanomaterials. Address the lack of information available 
on the identity and location of manufacture or use of 
engineered nanomaterials with high commercial 
potential and the lack of worker exposure data. Conduct 
12 field investigations at sites where engineered 
nanomaterials are handled and manufactured. The 
focus of these investigations is to be on nanomaterials 
of interest to NIEHS and NIOSH. Give priority to 
materials on the Organisation for Economic Co-
operation and Development’s list of representative 
manufactured nanomaterials as well as those that are 
receiving increased attention due to requests to 
manufacture, use, or distribute in the United States. 
NIEHS, NIOSH NA March 2011 Interagency 
agreement 
Durability of nanoscale 
cellulose fibers in artificial 
human lung fluids 
Characterize the physicochemical properties and 
dissolution behaviors of nanoscale cellulose fiber 
materials in artificial lung fluids to determine their 
biodurability. 
NIOSH Institute of 
Occupational 
Medicined 
March 2009 Collaborative 
research 
Risk assessment of 
engineered nanoparticles 
Conduct short-term inhalation experiments in mice to 
investigate short-term kinetics and health effects (e.g., 
pulmonary, cardiovascular, and central nervous system 
responses) of one or two selected engineered 
nanoparticles. Develop risk assessment methods, 
including biomathematical models of exposure-dose 
response, sensitivity and uncertainty analyses, and 
extrapolation from in vivo studies in rodents to predict 
internal dose and risk in humans. Provide exposure data 
in workplaces where nanoparticles are produced or 
used and develop risk management strategies. 
NIOSH University of 
Massachusetts, 
Lowell 
June 2009 Contract Professional services for 
developing a guidance 
document: Safe Practices 
for Working with Engineered 
Nanomaterials in Research 
Laboratories 
Review the available scientific literature, conduct 
empirical measurements in laboratories, and apply best 
professional judgment to the development of a draft 
guidance document on safe practices for engineered 
nanomaterials in research laboratories. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIOSH Rice University’s 
International Council 
on Nanotechnology 
(ICON) 
August 2009 Contract Development and 
deployment of a wiki to 
share good risk 
management practices for 
engineered nanomaterials 
Develop a workspace for good risk management 
practice information, housed on the ICON 
GoodNanoGuide wiki. Using wiki technology for sharing 
risk management information, successful practices, and 
case studies, seek to provide NIOSH stakeholders and 
the public with an easy to use, familiar, flexible, and 
comprehensive platform to obtain critical occupational 
safety and health information. Discussion forums can be 
established for users to collaborate on a wide range of 
topics, including novel facility design solutions, improved 
control technologies, or creative risk characterization 
techniques. New users can engage the experienced 
user community for nanomaterial management advice. 
Developing a wiki-based information sharing platform 
through ICON has the potential for reducing barriers to 
providing information to a government site.  
NIOSH, Department of 
Defense (DOD) 
NA October 2009 Memorandum Examination of potential 
occupational exposures of 
engineered nanomaterial at 
the DOD: a preliminary 
framework for DOD and 
NIOSH 
Evaluate environment, safety, and occupational health 
issues related to the creation, handling, and use of 
engineered nanomaterials at facilities across all DOD 
agencies. This partnership can be effected across the 
DOD or on an individual basis (Department of Army, 
Department of Navy, etc.), dependent upon the degree 
of interest and need for such environmental, safety, and 
occupational health evaluations. 
NIOSH Battelle Memorial 
Institute Pacific 
Northwest Divisione 
March 2010 Memorandum of 
understanding 
Memorandum of 
understanding between 
Battelle Memorial Institute 
Pacific Northwest Division 
and NIOSH 
Combine the capabilities of NIOSH and Battelle to 
advance the fundamental science supporting the safety 
assessment of nanotechnologies. Specifically, NIOSH 
and Battelle seek to engage in a joint research program 
studying the comparative toxicity of commercially 
important nanomaterials (e.g., single-walled carbon 
nanotubes and silica). 
NIOSH Center for High-Rate 
Nanomanufacturing 
at the University of 
Massachusetts, 
Lowell 
August 2010 Contract Engineering controls for 
nanomaterial handling 
Use data from field research to evaluate the 
performance of available engineering controls and 
promote their use for nanomaterial manufacturing and 
handling. Develop guidance for safely handling 
nanomaterials. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIOSH ICON August 2010 Contract Develop and deploy a wiki 
to share good risk 
management practices for 
engineered nanomaterials: 
follow-on deployment and 
evaluation 
Perform follow-on deployment and evaluation tasks of 
work from previously completed contract. The objective 
of the platform, now known as the GoodNanoGuide, is 
to contribute to safety and health excellence by creating 
a generally accessible repository of critical safety and 
health research findings and best practice information to 
assist users in developing and administering effective 
safety and health programs to be used during the 
research, production, and use of engineered 
nanomaterials. GoodNanoGuide content is being 
contributed from a variety of sources, including private, 
government, and academic safety, health, and 
environmental practitioners and from the various 
national and international consortia that have been 
created to foster good practices. The long-range intent 
is to have a virtual warehouse (or library) where health, 
safety, and environmental professionals and the public 
can go to share information and collaborate on 
particular topics.  
NIOSH, Occupational 
Safety and Health 
Administration 
NA August 2010 Interagency 
agreement 
Guidance for nanomaterials 
workers 
Investigate and characterize potential hazards 
associated with manufactured nanomaterials, with the 
goals of developing and recommending occupational 
safety and health measures to protect workers who 
manufacture and handle these materials. Build upon 
ongoing collaboration to investigate a control-focused 
guidance strategy for assisting small business 
employers in identifying and controlling workplace 
chemical hazards. 
NIOSH Lovelace Respiratory 
Research Institutef 
September 2010 Contract Deposition of carbon 
nanotubes in a human 
respiratory tract replica 
Obtain measurement data on the deposition efficiency 
and size distribution of multi-walled carbon nanotubes 
and single-walled carbon nanotubes in a human 
respiratory tract replica. These data are to be used by 
NIOSH to calibrate and evaluate a preliminary 
biomathematical model to predict the deposition of 
airborne carbon nanotubes in the human respiratory 
tract. A key element of this research is to develop an 
approach to relate the carbon nanotubes particle 
morphology to their aerodynamic and diffusion 
diameters.  
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIOSH University of 
Massachusetts, 
Lowell, the Center 
for High-rate 
Nanomanufacturing 
September 2010 Memorandum of 
understanding 
NIOSH-Center for High-rate 
Nanomanufacturing 
partnership to advance 
research and guidance for 
occupational safety and 
health in nanotechnology 
Advance workplace health and safety standards and 
practices and strengthen the resulting nanotechnology 
workforce. The Center for High-rate 
Nanomanufacturing, as a part of this partnership, seeks 
to collaborate with NIOSH to provide a state-of-the-art 
platform for the discovery and dissemination of 
fundamental knowledge in the emerging interdisciplinary 
fields of nanotechnology, including nanoscience, 
nanoengineering, and nanobiotechnology for the 
purpose of jointly developing effective occupational 
safety and health guidance. 
NIOSH College of 
Nanoscale Science 
and Engineering of 
the University at 
Albany—State 
University of New 
York 
October 2010 Memorandum of 
understanding 
NIOSH-College of 
Nanoscale Science and 
Engineering of the 
University at Albany 
partnership to advance 
research and guidance for 
occupational safety and 
health in nanotechnology 
Establish a world-class intellectual and physical platform 
for occupational safety and health research, 
development, educational, and business initiatives 
leading to the discovery, demonstration, and 
deployment of new guidelines, recommendations, and 
findings relating to the potential human health impacts 
of exposure to engineered nanomaterials.  
NIOSH Applied Research 
Associates, Inc.g 
March 2011 Contract Development of a 
preliminary biomathematical 
model to predict deposition 
of carbon nanotubes and 
nanofibers in the respiratory 
tract of workers 
Extend the carbon nanotubes deposition model to 
accommodate additional input data on both 
aerodynamic and diffusion diameters, and on particle 
number concentration as well as mass concentration. 
An acceptable extended model is to provide predictions 
of the deposition of carbon nanotubes of different sizes 
and shapes (i.e., single-walled carbon nanotubes and 
multi-walled carbon nanotubes) in the human respiratory 
tract. The model is to be calibrated and evaluated—
evaluation includes determining the particle properties 
and model parameters that provide the best predictions 
of multi-walled carbon nanotubes and single-walled 
carbon nanotubes deposition in the human respiratory 
tract replica. The carbon nanotubes deposition model is 
to be linked with an initial model to predict carbon 
nanotubes clearance and retention in the respiratory 
tract. 
NIOSH ICON August 2011 Contract Develop content and 
evaluate dissemination 
through the 
GoodNanoGuide wiki 
Develop focused content that includes new work 
practices and case studies, moderating the wiki, 
providing user support, and conducting an evaluation of 
the effectiveness of the GoodNanoGuide. 
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Participating federal 
agencies 
Nonfederal 
partners Date initiated 
Type of 
collaboration Title Purpose 
NIOSH, NIST, DOD, 
Department of Energy 
Over 20 private 
sector entities 
Program first 
initiated in July 
2005; multiple 
site visits 
occurred 
between 
February 2008 
and October 
2011 
Letter of introduction Site visits by NIOSH for the 
purpose of evaluating 
engineered nanomaterials in 
the workplace 
Enter nanomaterial manufacturing facilities to 
characterize process and evaluate the potential for 
worker exposure to nanoparticles. NIOSH may publish 
information from the overall study in the primary 
literature, and may supplement its Approaches to Safe 
Nanotechnology document on its website to incorporate, 
in a de-identified manner, observations or findings 
specific to work practices, exposure controls, or risk 
management practices that come from the visit that may 
be of benefit to the rest of the nanomaterial 
manufacturing community. 
NIST, NIOSH, NIH Agreement with 
International Alliance 
for NanoEHS 
Harmonization;h 
other partners for the 
alliance also include 
over 10 private 
entities and 
international 
organizations; 
Collaborators include 
the European 
Commission’s 
Institute for 
Reference Materials 
and Measurements 
October 2008 Participation 
agreement 
International Alliance for 
NanoEHS Harmonization 
Create protocols for a limited number of in vitro and in 
vivo toxicology tests on a small number of 
representative nanoparticles to enable a “round robin” 
study with the goal to achieve inter-laboratory 
reproducibility of results and verify and/or validate 
predictability of in vitro assays for in vivo responses. 
This is to involve at least the use of nanomaterials and 
biologicals from a single source, and a single set of 
protocols. The implementation of a round robin 
laboratory set of tests based on these protocols. 
Ongoing and further development of protocols that take 
into consideration study design and methodology, 
nanomaterial physicochemical properties, and 
quantitative structure function relationships at the 
nanobio interface for in vitro and in vivo protocol 
development. A next phase is to involve round robin 
studies of common nanomaterials and biological 
systems, where independent laboratories are to choose 
a different set of agreed approaches to interrogate the 
biological end-points. 
Source: GAO analysis based on formal collaborative EHS research project agreements provided by NNI member agencies’ 
officials. 
aThis agreement funded a grant selected through the cooperative framework signed 
between EPA and the UK. 
bThe International Life Sciences Institute Research Foundation is a nonprofit organization 
based in Washington, D.C. that focuses on advancing the methods and application of 
science in risk assessment, human nutrition, and the prevention of obesity. 
cSAIC-Fredrick is a wholly owned subsidiary of Science Applications International 
Corporation and operates exclusively under a single, long-term contract to the National 
Cancer Institute. 
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dThe Institute of Occupational Medicine is an independent organization based in the UK that 
produces research, consulting, and other services related to occupational and 
environmental health, hygiene, and safety. 
eBattelle Memorial Institute is an independent research and development organization 
based in Columbus, Ohio. 
fThe Lovelace Respiratory Research Institute is a private biomedical research organization 
dedicated to improving public health through research on the prevention, treatment, and 
cure of respiratory disease. 
gApplied Research Associates, Inc. is a research and engineering company based in 
Albuquerque, New Mexico. 
hInternational Alliance for NanoEHS Harmonization consists of internationally recognized 
experts drawn from academia and other scientific institutions from around the world. It is 
currently chaired by the Centre for BioNano Interactions at University College, Dublin. 
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